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Background: Behavioural counselling with intensive follow-up for obesity is effective, but in
resource-constrained primary care settings briefer approaches are needed.
Objectives: To estimate the clinical effectiveness and cost-effectiveness of an internet-based behavioural
intervention with regular face-to-face or remote support in primary care, compared with brief advice.
Design: Individually randomised three-arm parallel trial with health economic evaluation and nested
qualitative interviews.
Setting: Primary care general practices in the UK.
Participants: Patients with a body mass index of ≥ 30 kg/m2 (or ≥ 28 kg/m2 with risk factors) identified
from general practice records, recruited by postal invitation.
Interventions: Positive Online Weight Reduction (POWeR+) is a 24-session, web-based weight
management intervention completed over 6 months. Following online registration, the website randomly
allocated participants using computer-generated random numbers to (1) the control intervention (n = 279),
which had previously been demonstrated to be clinically effective (brief web-based information that
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minimised pressure to cut down foods, instead encouraging swaps to healthier choices and increasing
fruit and vegetables, plus 6-monthly nurse weighing); (2) POWeR+F (n = 269), POWeR+ supplemented by
face-to-face nurse support (up to seven contacts); or (3) POWeR+R (n = 270), POWeR+ supplemented by
remote nurse support (up to five e-mails or brief telephone calls).
Main outcome measures: The primary outcome was a modelled estimate of average weight reduction
over 12 months, assessed blind to group where possible, using multiple imputation for missing data. The
secondary outcome was the number of participants maintaining a 5% weight reduction at 12 months.
Results: A total of 818 eligible individuals were randomised using computer-generated random numbers.
Weight change, averaged over 12 months, was documented in 666 out of 818 participants (81%; control,
n = 227; POWeR+F, n = 221; POWeR+R, n = 218). The control group maintained nearly 3 kg of weight
loss per person (mean weight per person: baseline, 104.4 kg; 6 months, 101.9 kg; 12 months, 101.7 kg).
Compared with the control group, the estimated additional weight reduction with POWeR+F was 1.5 kg
[95% confidence interval (CI) 0.6 to 2.4 kg; p = 0.001] and with POWeR+R was 1.3 kg (95% CI 0.34 to
2.2 kg; p = 0.007). By 12 months the mean weight loss was not statistically significantly different between
groups, but 20.8% of control participants, 29.2% of POWeR+F participants (risk ratio 1.56, 95% CI 0.96
to 2.51; p = 0.070) and 32.4% of POWeR+R participants (risk ratio 1.82, 95% CI 1.31 to 2.74; p = 0.004)
maintained a clinically significant 5% weight reduction. The POWeR+R group had fewer individuals who
reported doing another activity to help lose weight [control, 47.1% (64/136); POWeR+F, 37.2% (51/137);
POWeR+R, 26.7% (40/150)]. The incremental cost to the health service per kilogram weight lost,
compared with the control group, was £18 (95% CI –£129 to £195) for POWeR+F and –£25 (95% CI
–£268 to £157) for POWeR+R. The probability of being cost-effective at a threshold of £100 per kilogram
was 88% and 98% for POWeR+F and POWeR+R, respectively. POWeR+R was dominant compared with
the control group. No harms were reported and participants using POWeR+ felt more enabled in
managing their weight. The qualitative studies documented that POWeR+ was viewed positively by
patients and that health-care professionals generally enjoyed supporting patients using POWeR+.
Study limitations: Maintenance of weight loss after 1 year is unknown.
Future work: Identifying strategies for longer-term engagement, impact in community settings and
increasing physical activity.
Conclusion: Clinically valuable weight loss (> 5%) is maintained in 20% of individuals using novel written
materials with brief follow-up. A web-based behavioural programme and brief support results in greater
mean weight loss and 10% more participants maintain valuable weight loss; it achieves greater enablement
and fewer participants undertaking other weight-loss activities; and it is likely to be cost-effective.
Trial registration: Current Controlled Trials ISRCTN21244703.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 4.
See the NIHR Journals Library website for further project information.
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Plain English summary
Background
Obesity is increasing and causes major health problems. Intensive expert counselling about diet and
exercise works, but there is limited capacity to do this in general practice, where most people
are managed.
Methods
People in the ‘control’ group were give brief written advice plus 6-monthly follow-ups with a practice nurse.
This was compared with an internet-based intervention called Positive Online Weight Reduction (POWeR+)
to help change eating and exercise habits. Nurse support for POWeR+ was either by face-to-face support
(up to seven contacts) or remote support (up to five e-mails or brief telephone calls).
Results
A total of 818 people took part. The control group lost nearly 3 kg per person over 12 months. Compared
with the control group, participants in the face-to-face POWeR+ group lost 1.5 kg more, averaged over
12 months, whereas those in the the remote group lost 1.3 kg more. By 12 months, mean weight loss was
not significantly different between groups, but 20.8% of the control group, 29.2% of the face-to-face
group and significantly more of the remote group (32.4%) had lost ≥ 5% of their original body weight,
which is important to health. Costs to the NHS were lowest for the remote group, who were generally
doing fewer other activities to lose weight and felt more enabled to manage their weight. Interviews
confirmed that patients generally liked POWeR+ and health-care professionals liked supporting patients to
use POWeR+.
Conclusion
Compared with brief advice and occasional brief nurse follow-up, using an internet-based programme
(POWeR+) combined with brief support by a practice nurse results in more people achieving an important
amount of weight loss, and is cost-effective.
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Scientific summary
Background
Obesity is an epidemic with major downstream consequences for a range of health issues from
musculoskeletal pain, diabetes mellitus, cardiovascular and cerebrovascular disease to cancer. The National
Institute for Health and Care Excellence (NICE) has supported intensive expert dietetic counselling and
intensive follow-up, which is effective, but the resource requirements are a major barrier to widespread
implementation in resource-constrained primary care settings where most obesity is managed. An alternative
to a cadre of highly trained interventionists is to harness the capacity of the internet to help support behaviour
change. A systematic review of internet-based behavioural health-related interventions concluded that
web-based interventions are effective for supporting behaviour change, although with considerable
heterogeneity, and that interventions employing multiple theory-based techniques achieve the best results.
However, major heterogeneity was documented in the effectiveness of internet interventions, with a trend
towards better outcomes in interventions with additional personal support, so it remains very unclear how
much facilitation is needed for effective weight reduction, whether face-to-face support is necessary and/or
whether briefer remote support could suffice. Using the person-based approach, we previously developed an
augmented web-based intervention for weight management in primary care, the Positive Online Weight
Reduction (POWeR+) programme, a prototype version of which (POWeR) helped to support weight loss in a
feasibility study.
Objectives
Among obese patients or overweight patients with significant comorbidities in primary care, we wanted
to compare the effect of three brief approaches with an intervention that could feasibly be applied.
We chose to use for a control group brief advice sheets for food swaps and increasing fruit and vegetable
consumption, which we had previously shown to help with weight control without expert dietetic
input. Compared with this group we wanted to estimate the incremental clinical effectiveness and
cost-effectiveness of (1) the internet-based behavioural intervention with face-to-face support as needed
(POWeR+F) and (2) the internet behavioural intervention with remote support (POWeR+R).
Methods
This was an individually randomised, three-arm parallel trial. Participants with a body mass index of
≥ 30 kg/m2 (or ≥ 28 kg/m2 with additional risk factors of hypercholesterolaemia, hypertension or diabetes
mellitus) were identified from general practice electronic records. They were then recruited by postal
invitation.
The POWeR+ intervention was developed previously: this is a 24-session web-based weight management
intervention consisting of a series of 24 brief (two-page) maintenance-oriented sessions for up to 6 months
and links to encourage patients to continue to use the website to track their weight at least fortnightly
(preferably weekly) until they have formed healthy eating habits that sustain weight management without
the need to access the website. Tailored feedback was provided, giving encouragement if participants
maintained weight loss (e.g. reminders of health benefits accrued); if weight increased, this triggered new
reminders, personalised messages, appropriate goal-setting, boosting motivation, and planning for and
overcoming difficulties.
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Following consent and online registration with the POWeR+ website, patients were randomly allocated
using computer-generated random numbers (in a 1 : 1 : 1 ratio) by the automated intervention website
to either:
1. control group – receiving only brief web-based information about healthy food swaps and eating
five fruits and vegetables a day
2. POWeR+F – access to POWeR+ and subsequent face-to-face nurse support (up to seven contacts)
3. POWeR+R – access to POWeR+ and remote nurse support of up to five brief e-mail/telephone contacts.
All participants were given appointments to be followed up at 6 and 12 months. The primary outcome
was the estimated average weight reduction from available data over 12 months. An important secondary
weight outcome was the proportion achieving a clinically important 5% reduction in weight at 12 months.
A range of other secondary outcomes was also measured [liver function tests, indices of metabolic
syndrome (waist circumference, high-density lipoprotein, triglycerides, blood pressure, fasting glucose),
reported fruit and vegetable consumption and reported physical activity]. Resource use was estimated
from the medical records and health-related quality of life measured using the EuroQol-5 Dimensions
(EQ-5D) instrument. Cost-effectiveness (cost per kilogram lost) and cost–utility (cost per quality-adjusted
life-year) analyses were performed. However, completion of the EQ-5D was limited and so the cost per
kilogram analysis was our primary economic analysis. We were also able to use previous modelling by
NICE, which had demonstrated that at least 1 kg per-person weight loss among overweight or obese
adults, if maintained for life, is likely to be cost-effective, provided that the cost per person of intervening is
< £100. Thirty-one patients and 19 health professionals who took part in POWeR+ agreed to participate
in an interview to discuss their perceptions about using POWeR+. Interviews were transcribed and
thematically analysed.
Results
Fifty-six general practices agreed to participate in the study and 818 eligible individuals from these
practices were randomised from January 2013 to March 2014. Of these, 439 had a weight recorded at the
6-month follow-up and 666 had a weight recorded at the 12-month follow-up. Of the 666, 510 (76.6%)
were blinded weights, 28 (4.2%) were unblinded weights and 128 (19.2%) were reported weights.
The groups were well balanced at baseline.
The control group achieved a reduction in weight of nearly 3 kg (baseline weight 104.4 kg, 6-month
weight 101.9 kg and 12-month weight 101.7 kg). Compared with the control group, POWeR+F
participants achieved an estimated additional weight reduction of 1.5 kg averaged over 12 months
[95% confidence interval (CI) 0.6 to 2.4 kg; p = 0.001] and POWeR+R participants achieved a 1.3 kg
weight reduction (95% CI 0.34 to 2.2 kg; p = 0.007). At 12 months, although there were no statistically
significant differences in mean weight loss between groups, 20.8% of the control group, 29.2% of the
POWeR+F group (risk ratio 1.56, 95% CI 0.96 to 2.51; p = 0.070) and 32.4% of the POWeR+R group
(risk ratio 1.82, 95% CI 1.31 to 2.74; p = 0.004) had maintained a clinically important 5% weight
reduction. The POWeR+R group included fewer individuals who reported doing another activity to help
lose weight [control: 47.1% (64/136); POWeR+F: 37.2% (51/137); POWeR+R: 26.7% (40/150)]. The
estimated incremental overall cost to the health service per kilogram weight lost compared with the
control group was £18 (95% CI –£129 to £195) for POWeR+F and –£25 (95% CI –£268 to £157) for
POWeR+R. The probability of being cost-effective at a threshold of £100 per kilogram lost was 88% and
98%, respectively. POWeR+R was dominant compared with the control. This makes it very likely that both
interventions are cost-effective at current willingness-to-pay thresholds, with the most cost-effective
intervention being POWeR+R.
The qualitative study with health-care professionals (HCPs) found that they generally enjoyed supporting
patients using POWeR+ and often perceived POWeR+ as superior to the weight-loss services that were
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available in their practices. HCPs also highlighted a number of challenges that they faced in providing
support for POWeR+, which can be addressed in revised versions of the website. The qualitative study
with patients found that POWeR+ was viewed positively, as was nurse support for POWeR+, and that if
POWeR+ is used remotely the option of contacting the nurses if necessary was important.
Implications for health care
Weight loss is maintained for some individuals by promoting novel written materials with occasional brief
nurse follow-up in primary care. However, more people can achieve clinically important weight reduction
with a web-based behavioural programme and brief remote follow-up, individuals feel more enabled to
manage their weight and undertake fewer other weight-loss activities, and it is likely to be cost-effective.
Future research implications
1. Many individuals did not continue to use the POWeR+ website and, given the evidence that those who
did lost more weight, a key research priority is to identify the most clinically effective and cost-effective
ways of continuing to engage more individuals.
2. Given the utility of POWeR+ with brief support in primary care, the question then arises of what public
health benefit might accrue from using POWeR+ in community settings, and what magnitude and
nature of support is necessary, such as a central facilitator or pharmacy support, in order to achieve
effective weight control.
3. Very few participants were engaged in using drug management of their weight problems, despite
this being intended as part of the package, and few individuals increased physical activity; an
implementation study to develop and trial a complex intervention to address both these issues
is warranted.
4. Future research to test the clinical effectiveness, acceptability and feasibility of similar methods for
providing human support for digital interventions in a range of health conditions is needed.
Trial registration
This trial is registered as ISRCTN21244703.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
Scientific background
Obesity is a major threat to public health,1,2 the prevalence has risen sharply3 and the vast majority of
obese patients are managed in primary care.4 For some time systematic reviews,4 including those from the
National Institute for Health and Care Excellence (NICE),5 have advocated a dietary and physical activity
intervention supported by intensive behavioural techniques. The NICE economic model6 estimated that if
trial results from other settings could be extrapolated to the skills mix, resource availability and setting of
primary care, then intervention is likely to be cost-effective. The trials identified in the NICE review5 mostly
had expert lifestyle and behavioural input, and intensively followed up patients (on average 13 times per
year during the first 12 months).5
An average practice with three general practitioners (GPs) and 5500 patients will have > 1300 obese
patients. There is a demand from obese patients for primary care to provide longitudinal programmes of
personalised support, but dropout from intensive face-to-face programmes is typically high and most
practice staff have neither the training nor the time to implement intensive obesity management
programmes based on one-to-one counselling, or even group counselling, to cope with such numbers.7
The problem will become worse as the obesity epidemic progresses. Therefore, it is not feasible to apply
current NICE recommendations in primary care because the high-level dietetic expertise required is not
available and it is impossible to free up enough staff time for counselling and follow-up, particularly given
the progressively resource-constrained environment in primary care. A research priority identified by NICE
in 20065 was to develop and assess interventions in primary care, and also to assess the scope for less
resource-intensive interventions in a primary care setting.
A review of studies in primary care8 using strict criteria for inclusion (e.g. excluding those with > 30%
attrition at 12 months, which is common in studies of obesity and so may not be an appropriate exclusion)
also concluded that there was very little evidence of studies using appropriately intensive behavioural
counselling in primary care and suggested the need for using trained interventionists.
Rationale for this research
An alternative, or addition, to a cadre of highly trained interventionists is to harness the capacity of the
internet to help support behaviour change.
A systematic review of internet-based behavioural health-related interventions9 concluded that web-based
interventions were effective for supporting behaviour change, although with considerable heterogeneity,
and that interventions employing multiple theory-based techniques achieved the best results.
Heterogeneity in the effectiveness of internet interventions may be, in part, due to the level of support,
with a trend towards better outcomes in interventions with additional personal support,10,11 so it remains
very unclear how much facilitation is needed for effective weight reduction, whether face-to-face
support is necessary and/or whether briefer remote support could suffice. It is also unclear whether such
interventions work better than using novel but simple written materials that do not emphasise cutting
out or cutting down favourite foods, but instead promote healthy food swaps and increased fruit and
vegetable consumption, which we have shown aid modest weight reduction.12
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Development of the intervention
Key elements of the content of the website
l Choice of diet: low calorie versus protein-sparing low carbohydrate. The NICE review,5 using the previous
National Institute for Health Research (NIHR)’s Health Technology Assessment review’s terminology,4
documented that ‘protein-sparing’ low-carbohydrate diets are likely to be as effective for weight loss as
a low-calorie diet with no major disadvantage for major cardiovascular risk factors. However, a major
concern with low-carbohydrate diets is the limiting of fruit and vegetable consumption, which is likely to
be harmful to health13–15 and is discouraged by NICE guidance.5 We developed and piloted a modified
version of a low-carbohydrate diet that encourages high fruit and vegetable consumption, is compatible
with longer-term healthy eating and achieved similar weight loss to a low-calorie diet in piloting. In
piloting, our patients fed back a strong request that some choice of diets should be allowed and also
that when initiating a low-carbohydrate diet, a 20-g induction phase is unrealistic and difficult to
comply with.
l Physical activity. NICE documented that physical activity (defined as at least 2–2.5 hours of moderate-intensity
physical activity per week), in addition to diet (600 kcal/deficit or low fat), is likely to be more effective than
diet alone (a difference of –1.95 kg, 95% CI –3.22 to –0.68 kg) at 12 months. This is supported by other
systematic reviews of weight loss and maintenance.16 There is debate about the level of physical activity
required for maintenance of weight; the average time spent in moderate-intensity physical activity in the
systematically reviewed randomised trials is 180–200 minutes per week (i.e. about 35 minutes per day),17 but
higher levels of activity were needed in the observational studies.17 We proposed offering pedometers to help
initiate and maintain physical activity, supported by systematic review evidence which demonstrates that
pedometers help increase physical activity by 26.9%, particularly if a step goal is used, and significantly
decrease body mass index (BMI) [by 0.38 kg/m2, 95% confidence interval (CI) 0.05 to 0.72 kg/m218].
l Behavioural component. A combination of diet and cognitive–behavioural therapy probably increases
weight loss (–7.66 kg; 95% CI –11.96 to –3.36 kg) compared with diet alone.5 The cognitive–behavioural
approach we have developed is in line with NICE guidance and draws on existing theory and evidence.
The approach emphasises that forming ‘healthy habits’ that can be maintained long term rather than
following prescriptive, complex or intrusive eating plans that are not sustainable.19,20
Initial development of the prototype intervention
Research for Patient Benefit funded the initial development of the intervention. Using the person-centred
approach,21 we developed an internet site to help support nurse-led weight loss in primary care – the
Positive Online Weight Reduction (POWeR) programme. The Research for Patient Benefit-funded website
was a prototype version and we demonstrated that this helped to support weight loss in a feasibility
study.22 Participants chose a low-calorie or a low-carbohydrate diet, and either a walking plan (with a
supplied pedometer) or a self-selected mixture of physical activities, emphasising sustainable habits. The
format was a set of 12 weekly sessions, teaching active cognitive and behavioural self-regulation
techniques (‘POWeR tools’), with evidence for their effectiveness and examples of success (‘POWeR
stories’). A food diary in session 1 helped to identify foods to omit or replace and a goal-setting tool
obliged patients to choose goals from preset choices (e.g. avoid ‘red’ foods, eat ‘amber foods’ only once a
day, reduce main meal portion sizes by 25%, avoid all high-calorie/carbohydrate snacks or drinks). At
subsequent sessions, goals were reviewed with feedback (e.g. positive feedback if successful, advice on
overcoming barriers if unsuccessful). Session 2 covered getting support and session 3 covered physical
activity. This was followed by a choice of weekly sessions covering cravings, relapse, increasing physical
activity, emotional eating, eating when busy, environment restructuring, alcoholic and non-alcoholic drinks,
and eating out.
Development of the full intervention
Following the success of the feasibility study, the prototype version of the POWeR programme was
developed further as POWeR+ – the development of which was finalised during the current grant from
NIHR’s Health Technology Assessment programme.
INTRODUCTION
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The POWeR+ web-based intervention
POWeR+ is a theory- and evidence-based intervention that is designed to teach patients self-regulation
and cognitive–behavioural techniques and that aims to help them to form sustainable eating and physical
activity habits for long-term weight management. POWeR+ was developed, as with POWeR, using the
person-based approach to maximise acceptability, feasibility and engagement.22–25 We finally created a
series of 24 web-based sessions lasting up to 6 months with novel content, links to external content and
e-mail reminders to encourage patients to continue to use the website weekly to track their weight, set
and review eating and physical activity goals, and receive personalised advice. After entering their weight
and whether or not they had achieved the goals they had set themselves the previous week, patients
receive tailored feedback giving encouragement if maintaining weight loss (e.g. reminders of health
benefits accrued) and meeting goals. Weight gain and failing to meet goals triggers automated
personalised advice, such as appropriate goal-setting and planning, boosting motivation, overcoming
difficulties and recovering from lapses (see Appendix 1).
Having developed the internet-based intervention, we chose to trial it in comparison with an active control
group – a brief approach using brief written materials to support food swaps and increased fruit and
vegetable consumption. We have previously shown this to control weight well, achieving in the order
of a 2% reduction in weight compared with providing a simple advice booklet.12
Objectives
Compared with a brief intervention promoting brief written materials to support food swaps and increased
fruit and vegetable consumption, we report the incremental effectiveness of (1) an internet-based
behavioural intervention (POWeR+) with face-to-face support as needed (POWeR+F) and (2) an internet
behavioural intervention with remote support (POWeR+R).
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Chapter 2 Methods
Study design
This was an individually randomised parallel-group study.
The control group received a brief but active intervention; the rationale was to minimise the pressure to
cut down favourite foods, but instead to swap less healthy foods for healthier choices (the swap sheet) or
to increase healthy foods (fruit and vegetables sheet). It was chosen for its simplicity to provide brief
advice, which we have previously shown to control weight well.12
We chose an individually randomised design because, with structured advice in each group, we have been
able to minimise contamination in previous trials and an individually randomised design has the additional
advantage of minimising cluster effects.
This was a very pragmatic trial to provide the most realistic estimates of effectiveness, so participants were
not constrained from pursuing other activities in any study group (e.g. attending commercial slimming clubs).
Trial registration and ethics
The trial was registered on 16 March 2012 [International Standard Randomised Controlled Trial Number
(ISRCTN) 21244703] and ethics approval was given by the National Research Ethics Service Committee
South Central Southampton B First Multicentre Research Ethics Committee (approved 19 December 2011;
reference number 11/SC/0455).
Participant inclusion and exclusion criteria
Patients with a BMI of ≥ 30 kg/m2 (or ≥ 28 kg/m2 with additional risk factors of hypertension, diabetes
mellitus or hypercholesterolaemia) documented in GP case records4 were eligible.
Patients were excluded if they had current major mental problems, such as psychosis, or were very ill
(e.g. severe left ventricular failure), that is, they had difficulty completing outcomes, were unable to change
diet, were pregnant or breastfeeding, or had a perceived inability to walk 100 m (physical activity difficult).
Recruitment: invitation of patients/recruitment
General practices in the south of England (recruited around the centres of Southampton and Oxford)
identified participants from their electronic records. Up to 100 patients from each practice were randomly
chosen and invited, by letter, to a screening appointment to confirm eligibility. Patients could also be
referred opportunistically when seen in clinics run by practice nurses or doctors (Figure 1).
Informed consent
During the screening appointment, the study was explained and informed written consent was
taken. Participants were given details of how to log in and register with the LifeGuide website
(www.lifeguideonline.org/), POWeR+.
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Randomisation/group allocation
On registering with the study website, participants were presented with baseline questionnaires, on
completion of which they were automatically randomised using computer-based random numbers by the
website to one of three feasible interventions in primary care:
1. Control group: evidence-based advice and simple materials to support behaviour change, and follow-up.
Those randomised to the control group were taken to pages of the POWeR+ website containing two
brief, structured, printable pages of advice about a healthy diet (healthy food swaps and NHS 5-a-day
leaflet27). These materials had previously been developed by the Institute of Food Research, and had been
trialled by us in primary care, resulting in modest weight loss (around 2%) compared with a generic
advice booklet.12 To enhance retention in the control group, participants were informed that this
3059 patients invited from 
25 practices (31 practices did not
return this information)
830 participants assessed 
for eligibility
Participants ineligible
(n = 4)
• Low BMI, n = 2
• Unable to walk 100 m, n = 2
Withdrew
(n = 51)
Lost to follow-up
(n = 101)
• Control, n = 18
• Face to face, n = 15
• Remote, n = 18
Reasons for withdrawal
• Situation changed 
   (e.g. pregnancy, moved 
   house), n = 18
• Disliked their group, n = 8
• No time or changed 
   mind, n = 4
• No reasons given, n = 21
Face to face
(n = 269)
826 patients from 56 practices
randomised and 
provided baseline weight
Remote
(n = 270)
Control
(n = 279)
Provided 6-month
follow-up weight
(n = 439)
Remote
[n = 155
(57%)]
Face to face
[n = 148
(55%)]
Control
[n = 136
(49%)]
Provided 12-month
follow-up weight
(n = 666)
Remote
[n = 218
(81%)]
Face to face
[n = 221
(82%)]
Control
[n = 227
(81%)]
Participants ineligible 
post randomisation 
(low BMI)
(n = 8)
• Control, n = 4
• Face to face, n = 3
• Remote, n = 1
FIGURE 1 The CONsolidated Standards Of Reporting Trials (CONSORT) flow diagram: flow of participants in
the trial. This figure has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence
(https://creativecommons.org/licenses/by/4.0/).
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intervention had been shown to support weight loss. For follow-up, nurses arranged brief 5- to
10-minute appointments with sufficient time to measure weight at 6 months and 12 months, but not
to provide extensive counselling.
2. POWeR+F: web intervention with face-to-face appointments for nurse support. The rationale for this
intervention was to provide automated behavioural counselling with just three scheduled (and four
optional) face-to-face nurse support sessions, thus requiring substantially less health professional skill
and time than the evidence-based lifestyle interventions documented in the NICE review,5 and, hence,
much easier to implement in the NHS. In addition to 6-monthly weighing, as in the control group,
participants had three scheduled face-to-face appointments in the first 3 months and then up to four
more during the next 3 months, if needed. Weight gain on two consecutive logins triggered an
automated e-mail to the nurse advising that the patient required further support. Patients could also
request additional support.
3. POWeR+R: web intervention with remote support. The rationale here was to test whether or not even
briefer professional support for the web intervention could be effective. Patients could access the same
web-based intervention as in the face-to-face group. In addition to 6-monthly weighing, as in the
control group, participants had three scheduled telephone or e-mail contacts and up to two optional
telephone/e-mail contacts during the first 6 months (triggered by weight gain or patient request as in
the face-to-face group). This level of support was confirmed as acceptable and helpful during the
development and piloting stages.
Data collection and management
Baseline assessment
Participants had appointments with the practice nurse at baseline to record baseline measures and to
provide the questionnaire to participants.
Follow-up
Participants were mailed the questionnaire again at 6 months and 1 year with two further mailings to
non-responders.
Practice nurses saw individuals for a follow-up appointment to measure weight at 6 months and
participants also had a visit by a nurse researcher blinded to the group to perform a weight measurement
at 12 months. Where a visit to obtain a blinded weight measurement was not possible, we used practice
nurses’ recorded weights and, where that was not possible, we used participants’ reported weight.
Notes review
During the available follow-up time all patients’ notes were reviewed to document consultations, returns,
time to return, reasons for returns, complications, NHS resource use and any subsequent referrals.
Measures
Weight reduction averaged over a 12-month period, measured lightly clothed, without shoes, where
possible at the same time each day, and using automated Tanita digital scales (Tanita Corporation of
America Inc., Arlington Heights, IL, USA), was the primary outcome.
A secondary weight outcome was the proportion of participants maintaining a 5% weight loss or loss of
around 4–5 kg . This is very likely to be important clinically (a reduction of 3–5 kg has a significant impact
on the incidence of diabetes mellitus28,29) and it allows direct comparison with a previous UK trial from
primary care settings,30 which published its results after our study commenced.
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Secondary outcomes
l Physical activity: the validated Godin leisure-time physical activity questionnaire.31
l Food and drink consumption: using the brief Food Frequency Questionnaires for major food groups as
well as alcohol.
l Indices of the metabolic syndrome:32 three out of five of elevated waist circumference (> 94 cm in
males, 80 cm in females), triglyceride concentration of ≥ 1.7 mmol/l, reduced high-density lipoprotein
cholesterol (< 1.00 mmol/l in males and < 1.3 mmol/l in females), elevated blood pressure (BP) (systolic
BP of > 130 mmHg or diastolic BP of > 85 mmHg, or treatment of high BP) or elevated fasting glucose
(≥ 5.6 mmol/l). We also proposed exploring the use of a continuous outcome based on the mean
z-score of each component of the syndrome for each individual (or mean rank as appropriate),
supported by empirical evidence of a close factor structure among the variables.33
¢ Waist: nurses measured the waist midway between the lower ribs and the iliac crest34 as well as
height to allow estimation of BMI. Fat mass was measured using Tanita scales.
¢ BP: measured three times (after 5 minutes) using a validated OMRON BP monitor (OMRON
Healthcare UK Ltd, Milton Keynes, UK).
¢ Serum measures: liver function tests, serum cholesterol/high- and low-density lipoprotein/
triglycerides, glucose, glycated haemoglobin (HbA1c) and ferritin [important to measure because of
reduced cereal consumption (a key source of iron) in the low-carbohydrate diet].
l Patient enablement: we used a modified version of the enablement scale.35
l EuroQol-5 Dimensions (EQ-5D): the EQ-5D provided a measure of quality of life for economic analysis.
l Self-reported behavioural adherence: website usage (frequency and duration of logins, options selected
and all data inputted).
l Usage of other weight management activities: perceptions of nurse support.36
¢ Habits: a modified self-reported habit index measured physical activity and dietary habits.37
¢ Intention to change behaviour: based on the theory of planned behaviour components
(attitudes, social norms, perceived behavioural control).38
¢ Other measures: sociodemographic data (age, gender, education, internet experience and social
deprivation indices based on postcode) were also recorded.
Sample size
We wished to compare each of the intervention groups primarily with the control group, but also
potentially with each other, so we allowed for an alpha of 0.017 (i.e. 0.05/3). For the primary outcome
(weight) we estimated that a standardised effect size of 0.33 [equivalent to a 2–3 kg difference, assuming
a standard deviation (SD) of change of 6.5–7.5 kg36,39] and 80% power required 174 patients per group
with complete data, or 654 patients in total allowing for a 20% loss to follow-up. Following liaison with
both the funder (NIHR’s Health Technology Assessment programme) and the Trial Steering Committee,
the power calculation was revised to allow for modest clustering at practice level if significant clustering
was found; we assumed, on average, a minimum of 18 patients per practice to achieve 15 patients at
follow-up, of whom roughly five or six were in each of the two intervention groups at follow-up, assuming
five participants per group in each practice, for an intracluster correlation coefficient of 0.05 {i.e. a design
effect of 1.2 = 1 + [(5 – 1) × 0.05]}. This resulted in a minimum of 654 × 1.2 = 785 patients. This was a
conservative calculation because we made no allowance for repeated measures.
METHODS
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Statistical analysis
Primary analysis
A mixed multivariate regression model was chosen to estimate the average impact over 12 months and to
enable data to be used from anyone who had 6- or 12-month data, controlling for weight at baseline,
gender, age, smoking, diabetes mellitus, medications (including orlistat used at baseline), any comorbidities,
deprivation (Indices of Multiple Deprivation40) and any clustering by practice.
Missing data
The primary analysis was the intention-to-treat analysis using both measured and reported weights, and
imputing data by multiple imputation. Secondary, less conservative, analyses were of complete cases and
also using measured weights only.
Potential clustering effects
Although the trial was individually randomised, we controlled for any clustering by practice in the analysis.
In the repeated measures model, after controlling for baseline weight, the intracluster correlation
coefficient at the practice level was 0.01 (95% CI 0.003 to 0.09) and at the participant level was 0.74
(95% CI 0.69 to 0.78).
Patient and public involvement
Weight Concern was a partner in this project, and the study team requested named individuals to be part
of the team. Weight Concern preferred, instead, to provide a panel-based input, arguing cogently that a
more balanced input would be provided. The input was indeed very helpful, particularly during the
development of the intervention. Nevertheless, in retrospect, patient and public involvement input would
still have been strengthened by engaging named individuals to contribute, perhaps sourced through
additional channels.
Subgroup analyses
We explored estimates of effect in subgroups according to baseline waist measurement (high vs. low
waist circumference) and the presence of metabolic syndrome. We assessed outcome (weight, reported
behaviour change, measured behaviour change) according to website usage and to the type of diet chosen
by patients.
Other analyses
We assessed the relationship between weight changes compared with the changes in metabolic variables.
Changes to the protocol
Based on the advice of the Trial Steering Committee we increased the sample size to allow for clustering,
as necessary. A repeated measures analysis of variance for the principal continuous outcome (i.e. weight)
was originally proposed but could be undertaken only in those who completed both the 6- and 12-month
follow-up, thus unnecessarily losing data; therefore, the analysis was changed to mixed multivariable
regression modelling. We originally planned for one-third of the sample to be randomised to wear activity
monitors to allow for more precise estimation of physical activity, but the logistics of organising this
subsample at a time of intensive attempts to achieve high follow-up for the primary outcome became too
difficult. Similarly, piloting suggested that intensive follow-up for anything but the primary outcome would
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result in participants dropping out, so all the effort of follow-up concentrated on achieving as high a rate
of follow-up for the primary outcome as possible. Although the original protocol justified the sample size
based on a clinically important weight reduction, the proportion maintaining a clinically important weight
loss was not originally specified. We rectified this omission by specifying a secondary weight outcome
as the proportion maintaining a 5% weight loss, or around 4- to 5-kg weight loss. This is important
clinically (a reduction of 3–5 kg significantly reduces the incidence of diabetes mellitus28,29) and it allows a
direct comparison with the previous UK trial from primary care settings,30 which published its results after
our study commenced.
Compliance with intervention
Compliance with the use of the POWeR+ intervention using the LifeGuide software version 1.0.7.30
(University of Southampton, Southampton, UK) was documented automatically by the website, which
recorded the number of sessions completed and the time taken.
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Chapter 3 Trial results
Practice recruitment
Fifty-six general practices were recruited in the south of England around the main study centres
(Southampton and Oxford).
Participant recruitment
A total of 818 eligible individuals were recruited and randomised between January 2013 and March 2014.
Baseline comparability
Table 1 shows the baseline characteristics of the groups and shows that groups are mostly well balanced.
Losses to follow-up and missing data
Of the 818 individuals, 439 had a weight recorded at the 6-month follow-up and 666 had a weight
recorded at the 12-month follow-up. Of the 666, 510 (76.6%) were blinded weights, 28 (4.2%) were
unblinded weights and 128 (19.2%) were reported weights. The reported weights were similar in each
group (control, n = 40; POWeR+F, n = 48; POWeR+R, n = 40).
Primary outcome
Mean weight reduction
Tables 2 and 3 show the mean weights at baseline and follow-up. The complete data suggest that the
control group maintained a weight loss of nearly 3 kg at both 6 and 12 months, although the imputed
data suggest less weight loss at 6 months (imputed weight 6 months, 103.16 kg; 12 months, 102.17 kg).
TABLE 1 Baseline characteristics
Characteristic
Group
Control: brief verbal
and online healthy
eating advice
POWeR+F: access to
website and brief
face-to-face support
POWeR+R: access to
website and brief
remote support
Female, n/N (%) 185/279 (66.31) 175/269 (65.06) 160/269 (59.48)
Age (years), mean (SD) 52.69 (13.25) 53.70 (13.21) 54.74 (12.95)
Smoker, n/N (%) 24/279 (8.6) 21/269 (7.81) 25/269 (9.29)
Diabetes mellitus, n/N (%) 48/279 (17.20) 46/268 (17.16) 42/270 (15.56)
Orlistat use, n/N (%) 3/270 (1.11) 5/262 (1.91) 5/266 (1.88)
Comorbid condition, n/N (%) 48/281 (17.08) 55/269 (20.45) 55/272 (20.22)
Deprivation score,40 mean (SD) 14.32 (10.45) 13.73 (10.28) 13.29 (10.17)
Weight (kg), mean (SD) 104.38 (21.11) 102.40 (16.87) 102.93 (18.26)
BMI (kg/m2), mean (SD) 37.10 (5.97) 36.66 (5.36) 36.28 (5.65)
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
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Compared with the control group, for both the complete cases (Tables 4 and 5) and for the imputed
analysis (Table 6), there was a significant additional reduction in mean weight averaged over 12 months in
the POWeR+ groups. The primary imputed analysis documented that the POWeR+F group achieved an
estimated additional 1.5-kg reduction over the 12-month period (95% CI –2.4 to –0.6 kg; p = 0.001) and
the POWeR+R group an additional 1.3-kg reduction (95% CI –2.3 to –0.3 kg; p = 0.005). The secondary
analysis of only the complete cases over 12 months was slightly less conservative, with a greater weight
reduction compared with the control group (POWeR+F: –1.78 kg, 95% CI –2.8 to –0.8 kg; POWeR+R:
–1.6 kg, 95% CI –2.6 to –0.6 kg) (see Table 5). Considering individual time points, the mean weight
reduction was approximately 2 kg at 6 months compared with the control group in both POWeR+ groups,
but was smaller by 12 months (approximately a 0.5-kg difference).
TABLE 2 Mean weights (kg) at 6 and 12 months for complete cases
Group
Weight (kg), mean (SD); n
Time point
Baseline 6 months 12 months
Control 104.38 (21.11); 279 101.91 (19.35); 136 101.73 (19.57); 227
POWeR+F 102.40 (16.87); 269 97.55 (15.99); 148 98.56 (15.95); 221
POWeR+R 102.93 (18.26); 270 98.30 (18.34); 155 99.72 (18.88); 218
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 3 Complete cases: measured mean weight (kg) only
Group
Weight (kg), mean (SD)
Time point
6 months 12 months
Control 101.86 (19.95) 101.02 (18.26)
POWeR+F 98.58 (17.65) 98.19 (16.10)
POWeR+R 97.18 (16.67) 99.02 (18.13)
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 4 Complete cases: difference in weight (kg) compared with the control group
Group
Time point, difference (95% CI); p-value Over study period (repeated
measures), difference (95% CI);
p-value6 months 12 months
POWeR+F –2.90 (–4.09 to –1.71); < 0.001 –0.63 (–1.92 to 0.66); 0.340 –1.56 (–2.47 to –0.65); 0.001
POWeR+R –2.42 (–3.59 to –1.24); < 0.001 –0.63 (–1.93 to 0.67); 0.342 –1.30 (–2.21 to –0.39); 0.005
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TRIAL RESULTS
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Clinically important weight reduction
By 12 months, using data from complete cases, 18.5% (42/227) of the control group had maintained a
≥ 5% reduction in weight and 20.8% from the imputed data. The proportion maintaining clinically
valuable weight loss for POWeR+F, estimated from the imputed data, had waned a little between 6 and
12 months (36.8% vs. 29.2%), but was similar for POWeR+R (33.7% vs. 32.4%) (Table 7).
Adherence and the impact of adherence on weight reduction
Of the 539 participants randomised to the POWeR+ intervention groups, 524 started the first session and
404 completed all three core sessions (196 of the POWeR+R group and 208 of the POWeR+F group).
Participants completed an average of 10.97 (SD 12.65; range 0–52) weight and goal reviews; the average
was 10.16 (SD 11.92) in the POWeR+F group and 11.85 (SD 13.38) in the POWeR+R group. The median
number of nurse contacts was four (range 0–7) in both intervention groups, with a median of two
face-to-face, one telephone and one e-mail contacts in the POWeR+F group, and a median of one
telephone call and three e-mails in the POWeR+R group. There was around a 2.0- to 2.5-kg difference in
weight reduction for those who completed more than the first basic stage of the programme (Table 8).
There was no evidence of a significant difference in weight loss according to the type of diet chosen
(Table 9).
Other activities
For those returning the final questionnaire, almost half the people in the control group (47.1%; 64/136)
were doing another activity to help lose weight as opposed to 37.2% (51/137) in the POWeR+F group and
only 26.7% (40/150) in the POWeR+R group (Table 10).
TABLE 5 Complete cases: estimated differences in weight (kg) compared with control group based on measured
weight only
Group
Time point, estimated difference (95% CI); p-value Over study period (repeated
measures), estimated difference
(95% CI); p-value6 months 12 months
POWeR+F –3.20 (–5.00 to –1.39); 0.001 –1.02 (–2.27 to 0.22); 0.107 –1.78 (–2.81 to –0.76); 0.001
POWeR+R –3.22 (–5.03 to 1.41); < 0.001 –0.96 (–2.21 to 0.29); 0.134 –1.60 (–2.63 to 0.57); 0.002
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 6 Imputed data based on 50 imputations: difference in weight (kg) compared with control group
Group
Time point; , difference (95% CI); p-value Over study period (repeated
measures), difference (95% CI);
p-value6 months 12 months
POWeR+F –2.54 (–3.66 to –1.42); < 0.001 –0.37 (–1.66 to 0.92); 0.566 –1.49 (–2.41 to –0.58); 0.001
POWeR+R –1.97 (–3.18 to –0.76); 0.002 –0.58 (–1.88 to 0.72); 0.375 –1.27 (–2.19 to –0.34); 0.007
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
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Secondary outcomes
A range of secondary outcomes is shown in Tables 11–22. Owing to the priority to obtain follow-up for
weights, and the clear feedback from piloting that pressurising participants to have blood taken was
offputting, achieving high follow-up for blood samples was necessarily a secondary priority for the trial
team and so a minority of participants had follow-up blood measurements. As a result, even though
estimates use multiple imputation, the results for blood samples must be interpreted cautiously. What
results are available suggest a generally positive direction of outcomes in the POWeR+ groups (i.e. raised
high-density lipoprotein cholesterol, lower aspartate transaminase and alanine transaminase levels).
TABLE 9 Mean weights (kg) according to type of diet chosen by the participant
Diet
Weight (kg), mean (SD)
Time point
Baseline 6 months 12 months
Low calorie 102.68 (17.35) 98.12 (17.00) 99.25 (17.65)
Low carbohydrate 102.57 (18.00) 97.30 (17.86) 98.37 (17.46)
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 10 Additional activities undertaken over 12 months
Activities
Group, n/N (%)
Control POWeR+F POWeR+R
Take part in regular activity long enough to work up a
sweat
Rarely 50/135 (37.0) 38/134 (28.4) 39/146 (26.7)
Sometimes 57/135 (42.2) 69/134 (51.5) 77/146 (52.7)
Often 28/135 (20.7) 27/134 (20.2) 30/146 (20.6)
Take part in another weight-loss activity 64/136 (47.1) 51/137 (37.2) 40/150 (26.7)
Of these, the reported activities were:
Weight Watchers® (Weight Watchers International, Inc.,
New York, NY, USA)/Slimming World (Slimming World,
Alfreton, UK) (or similar) meetings
23/136 (16.9) 22/137 (16.1) 14/150 (9.3)
Another weight management website 0/135 (0.0) 4/136 (2.9) 4/150 (2.7)
Telephone application 13/136 (9.6) 8/136 (5.9) 10/149 (6.7)
Weight-loss pills 5/136 (3.7) 4/137 (2.9) 2/150 (1.3)
Health trainer programme 4/136 (2.9) 2/136 (1.5) 3/148 (2.0)
Exercise referral scheme 4/136 (2.9) 7/137 (5.1) 4/148 (2.7)
Another weight-loss scheme 8/136 (5.9) 13/136 (9.6) 8/149 (5.4)
Any other weight management method 22/97 (22.7) 13/87 (14.9) 8/103 (7.8)
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
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TABLE 11 Physical activity: Godin questionnaire at 12 months
Group Median physical activity score (IQR) Difference compared with control group (95% CI); p-value
Control 20 (11–33)
POWeR+F 25 (12–41) 2.49 (–2.72 to 7.70); 0.348
POWeR+R 21 (13–45) –0.90 (–5.97 to 4.17); 0.728
IQR, interquartile range.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 12 Liver function tests for complete cases
Group
Liver function test (units/l), crude mean (SD)
ALT (n= 329) AST (n= 303) Gamma-GT (n= 319)
Baseline 12 months Baseline 12 months Baseline 12 months
Control 30.17 (16.62) 30.23 (15.33) 30.99 (14.26) 29.38 (10.96) 39.18 (35.20) 38.65 (31.01)
POWeR+F 31.41 (17.48) 27.26 (14.06) 31.80 (13.79) 27.15 (9.36) 43.76 (46.55) 35.40 (26.10)
POWeR+R 31.26 (17.57) 27.68 (16.97) 30.73 (13.69) 27.80 (9.27) 38.04 (30.85) 40.19 (40.47)
ALT, alanine transaminase; AST, aspartate transaminase; gamma-GT, gamma-glutamyl transferase.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 13 Liver function tests: estimated differences using multiple imputation compared with control group at
12 months
Group
Liver function test (units/l), estimated difference (95% CI); p-value
ALT AST Gamma-GT
POWeR+F –3.01 (–6.59 to 0.57); 0.093 –2.21 (–4.77 to 0.35); 0.087 –3.06 (–9.87 to 3.74); 0.356
POWeR+R –2.72 (–6.08 to 0.64); 0.107 –2.02 (–4.38 to 0.34); 0.090 2.03 (–5.24 to 9.32); 0.568
ALT, alanine transaminase; AST, aspartate transaminase; gamma-GT, gamma-glutamyl transferase.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 14 Glucose, HbA1c and ferritin for complete cases
Group
Measurement, crude mean (SD)
Glucose, mmol/l (n= 338) HbA1c, mmol/l (n= 330) Ferritin, µg/l (n= 362)
Baseline 12 months Baseline 12 months Baseline 12 months
Control 5.68 (1.88) 5.88 (1.94) 40.49 (10.42) 41.09 (28.68) N/A 95.73 (94.77)
POWeR+F 5.91 (2.53) 5.83 (2.67) 42.00 (13.09) 38.78 (11.39) N/A 95.47 (84.16)
POWeR+R 5.64 (1.93) 5.64 (1.99) 40.07 (11.60) 38.74 (12.79) N/A 103.78 (76.24)
N/A, not applicable.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
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TABLE 15 Glucose, HbA1c and ferritin: estimated difference using multiple imputation compared with control at
12 months
Group
Measurement, estimated difference (95% CI); p-value
Glucose (mmol/l) HbA1c (mmol/l) Ferritin (µg/l)
POWeR+F –0.20 (–0.66 to 0.26); 0.375 –3.15 (–8.01 to 1.72); 0.192 –4.69 (–23.78 to 14.40); 0.616
POWeR+R –0.32 (–0.79 to 0.15); 0.176 –2.96 (–7.74 to 1.83); 0.213 5.86 (–12.63 to 24.36); 0.516
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 16 Cholesterol for complete cases
Group
Cholesterol (mmol/l), crude mean (SD)
Total (n= 346) HDL (n= 348) LDL (n= 218) Triglycerides (n= 286)
Baseline 12 months Baseline 12 months Baseline 12 months Baseline 12 months
Control 5.30 (1.24) 5.05 (1.26) 1.43 (0.37) 1.37 (0.32) 3.12 (1.03) 2.97 (0.98) 1.74 (0.96) 1.72 (0.82)
POWeR+F 5.19 (1.19) 5.18 (1.18) 1.40 (0.33) 1.47 (0.35) 3.02 (0.96) 2.94 (0.98) 1.72 (0.85) 1.75 (1.04)
POWeR+R 5.35 (1.33) 5.33 (1.20) 1.41 (0.36) 1.50 (0.38) 3.11 (1.05) 3.08 (1.10) 1.89 (1.59) 1.78 (1.49)
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 17 Cholesterol: estimated differences using multiple imputation compared with the control group at
12 months
Group
Cholesterol (mmol/l), estimated difference (95% CI); p-value
Total HDL LDL Triglycerides
POWeR+F 0.11 (–0.92 to 0.31);
0.270
0.08 (0.02 to 0.15);
0.010
0.01 (–0.19 to 0.22);
0.894
0.03 (–0.28 to 0.34);
0.826
POWeR+R 0.14 (–0.08 to 0.35);
0.204
0.10 (0.03 to 0.17);
0.006
0.06 (–0.16 to 0.28);
0.572
0.01 (–0.30 to 0.32);
0.937
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
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TABLE 18 Body fat percentage and BP for complete cases
Group
Measurement, crude mean (SD)
Body fat percentage (n= 454) SBP (mmHg) (n= 494) DBP (mmHg) (n= 494)
Baseline 12 months Baseline 12 months Baseline 12 months
Control 43.59 (7.08) 42.71 (7.20) 133.78 (17.84) 133.11 (18.61) 81.17 (10.64) 79.10 (10.79)
POWeR+F 43.86 (8.00) 41.40 (8.81) 132.28 (15.81) 133.31 (15.70) 80.97 (9.37) 79.89 (9.20)
POWeR+R 42.18 (7.79) 40.53 (8.42) 134.17 (17.00) 132.11 (17.08) 80.71 (10.00) 78.92 (9.71)
DBP, diastolic blood pressure; SBP, systolic blood pressure.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 19 Estimated differences in body fat percentage and BP using multiple imputation compared with the
control group at 12 months
Group
Measurement, estimated difference (95% CI); p-value
Body fat percentage SBP (mmHg) DBP (mmHg)
POWeR+F –0.96 (–1.83 to –0.08); 0.033 0.05 (–2.76 to 2.86); 0.973 0.67 (–1.12 to 2.46); 0.461
POWeR+R –0.53 (–1.47 to 0.42); 0.274 –2.72 (–5.56 to 0.12); 0.061 0.02 (–1.64 to 1.68); 0.979
DBP, diastolic blood pressure; SBP, systolic blood pressure.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
TABLE 20 Portions of foods eaten per day for complete cases
Food
Group, crude mean (SD)
Control POWeR+F POWeR+R
Baseline 12 months Baseline 12 months Baseline 12 months
Sweets 1.14 (1.33) 0.89 (0.87) 1.39 (1.66) 0.71 (0.98) 1.24 (1.61) 0.86 (1.32)
Cereals 1.92 (1.17) 1.67 (0.98) 2.02 (1.26) 1.45 (0.97) 1.97 (1.43) 1.40 (0.90)
Fatty foods 2.72 (1.85) 2.15 (1.67) 2.86 (2.01) 2.06 (1.45) 2.65 (1.83) 1.97 (1.32)
Salty snacks 0.33 (0.62) 0.19 (0.31) 0.33 (0.54) 0.16 (0.23) 0.31 (0.54) 0.15 (0.22)
Sweet drinks 0.49 (1.20) 0.22 (0.59) 0.38 (0.88) 0.11 (0.30) 0.48 (1.17) 0.24 (0.63)
Fruit and vegetables 3.70 (2.28) 4.63 (2.70) 4.02 (2.57) 4.46 (2.55) 3.85 (2.22) 4.63 (2.40)
Low-fat dairy 1.29 (1.44) 1.23 (1.36) 1.64 (1.51) 1.45 (1.53) 1.43 (1.64) 1.53 (1.54)
Ratio of high- to low-fat foods 2.66 (8.27) 1.54 (8.00) 1.52 (6.41) 1.43 (5.53) 2.39 (7.74) 1.39 (4.59)
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
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Fat mass and BP were recorded in the majority of participants at follow-up (in both cases > 450 individuals)
and, although there were no consistent changes in BP, fat mass reduced slightly in both POWeR+ groups
(see Tables 18 and 19). Participants in the control group reported healthy changes in many areas of food
consumption – with modest changes in sweets, fatty foods, and fruit and vegetables, and in the ratio of
high- to low-fat foods. In comparison with the control group, in the POWeR+ groups there were no
significant changes but there were trends in the reduction in sweets and cereals, and increasing low-fat
dairy foods. Participants felt significantly more enabled to manage their weight problem in the POWeR+
groups (see Table 22).
Subgroups
Metabolic syndrome
There was evidence of an interaction with the presence of metabolic syndrome (Table 23). The interaction
term for those having metabolic syndrome at 6 months was 3.04 (95% CI 0.33 to 5.74; p = 0.028) for the
POWeR+F group and 1.26 (95% CI –1.37 to 3.88; p = 0.348) for the POWeR+R group (i.e. POWeR+F was
more effective in those not having metabolic syndrome but only in the short term). At 12 months, the
interaction terms were 0.58 (95% CI –2.42 to 3.57; p = 0.707) for the POWeR+F group and 0.45 (95% CI
–2.51 to 3.41; p = 0.765) for the POWeR+R group.
Waist
We originally specified high waist measurements as a possible subgroup, but because none of the trial
cohort had low waist measurements this was not possible. We have instead explored whether or not there
is an interaction in those with above and below median waist measurements. There was no evidence of a
significant interaction at either 6 or 12 months. The interaction term at 6 months for those with an above-
median waist circumference was 0.99 (95% CI –1.46 to 3.44; p = 0.472) for the POWeR+F group and
0.23 (95% CI –2.21 to 2.67; p = 0.853) for the POWeR+R group. At 12 months, the interaction term was
0.51 (95% CI –2.12 to 3.13; p = 0.706) for the POWeR+F group and 1.69 (95% CI –1.00 to 4.37;
p = 0.218) for the POWeR+R group.
Harms
No harms were reported.
TABLE 22 Modified Patient Enablement Instrument
Group
Mean item score (SD)
Difference in PEI score compared with
control group (95% CI); p-valueBaseline 12 months
Control 3.19 (1.27) 3.23 (1.57)
POWeR+F 3.42 (1.19) 4.10 (1.28) 0.70 (0.39 to 1.01); < 0.001
POWeR+R 3.31 (1.26) 3.85 (1.35) 0.54 (0.24 to 0.85); < 0.001
PEI, Patient Enablement Instrument.
Note
This table has been reproduced from Little et al.26 under the terms of the CC BY 4.0 licence (https://creativecommons.org/
licenses/by/4.0/).
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Chapter 4 Economic evaluation
This section presents both a cost-effectiveness (cost per kilogram lost) and a cost–utility [cost perquality-adjusted life-year (QALY)] analysis. Results were compared with the threshold suggested by NICE
of £100 per kilogram lost if maintained over the long term.6
The economic analysis alongside this trial was influenced by aspects of the trial, including its size
(> 800 patients randomised), the low levels of research contacts with patients made feasible using
predominantly web-based support as opposed to person-based support, the involvement of 56 different
GP practices, each with its own nurse support, and reliance on practice case notes (mostly electronic) for
service use and on short, focused patient reports. The number, but not the duration, of contacts with
practice nurses was recorded. As a result, the costing of the interventions had to rely on assumptions,
which are tested in a sensitivity analysis.
Methods
The costing comprised two elements: one measuring the intervention cost alone, based on the cost of
internet plus that of nurse support; and the other measuring total cost, that is, the cost of the intervention
plus differences in the cost of NHS services. The perspective was that of the NHS and Personal Social
Services. The time horizon was 12 months. The implications of different cost scenarios were explored.
The main cost of the intervention was the nurse support time comprising face-to-face consultations,
telephone and e-mail contact. The cost of nurse support was based on trial data that documented the
number of contacts by type (face to face and by telephone and e-mail, all with the practice nurse).
Face-to-face contacts linked to the trial interventions were planned to be brief and last half as long as
normal visits; hence, these were assumed to cost 50% of standard practice nurse consultations. The time
taken for telephone contacts relative to face-to-face visits was based on the split for GPs between
face-to-face and other contacts provided in Personal Social Services Research Unit (PSSRU) unit costs.41
Telephone contacts were shorter than most telephone consultations as no new diagnosis and management
plan was being instituted; instead, patients were given brief support and signposted back to the POWeR+
resources, as appropriate. The time taken for e-mail contacts was put at 50% of that of telephone contacts
and, because e-mail contacts are normally quick, this may be an overestimate. These assumptions were
tested in sensitivity analyses. Nurse costs were costed using national costs per consultation for a practice
nurse.41 The unit costs used in costing the intervention are shown in Table 24.
The cost of the intervention comprised the cost of the website and the support offered to users. The cost
of providing a web intervention that could be used widely would be spread among many thousands of
individuals. We therefore put the cost of the website at £1 per person, based on the cost of providing and
maintaining the website, but this may overestimate its cost, were it to be made widely available.
The brief verbal intervention and supporting advice sheets in the control group were not costed separately,
but were assumed to be included in primary care consultations. Resource use data were extracted from GP
case notes 12 months after recruitment – covering medication, primary care visits, outpatient consultant,
accident and emergency attendance and hospital admission. Intervention-specific resource use was
recorded by study nurses.
The costing of medications was limited to those plausibly associated with obesity, that is, medications for
diabetes mellitus, BP, clotting/antiplatelet, musculoskeletal problems (back, hip and knee pain), and lipid
lowering and weight management. The names of these medications, dosage and days of use were recorded.
Prices were the listed pack price, the cost to the NHS. For drugs started before the trial or for which no
end date was recorded, we assumed the duration of use to be that of the trial (12 months). For all other
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obesity-related medications, if no duration of use data were available, we assumed the recommended
duration from the starting date. The unit costs of medications were those in the British National Formulary
in 2013–14 prices.43
Consultations in primary care, walk-in centres, and accident and emergency departments and outpatient
attendances were recorded and priced using PSSRU 2013/14 unit costs41 (see Table 24).
Data on all hospital admissions were also extracted. We used Healthcare Resource Group cost per episode
linked to cause of admission.43 Data on these unit costs and those for medications are available on request.
The outcomes were weight lost and QALYs. Data on weight were collected at 6 and 12 months, when
patients were weighed by the practice nurse. Health-related quality of life was measured by the EQ-5D,
completed by patients at baseline and at 6 and 12 months. The EQ-5D scores were expressed as utilities
using the national tariff, with interpolation using area under the curve.
Missing data were imputed using multiple imputation, as in the clinical analyses in Chapter 3.
Bootstrapping was applied to the imputed data to estimate costs, weights, QALYs and incremental
cost-effectiveness ratios (ICERs). Weights were analysed by repeated measure analyses. Estimates of the
differences in QALYs were adjusted by baseline EQ-5D scores. Pooled results of the bootstrapped analyses
were used to generate the 95% CIs around the estimates. In line with the approach that matches the
effectiveness analysis (where a reduction is indicated by a negative value), where costs are reduced we
have also indicated this with a negative value (in particular, the negative values for ICERs indicate that
there was an estimated reduction in costs for every kilogram of weight lost).
TABLE 24 Unit costs of primary care, other services and of interventions (2013/14 prices)
Service Unit cost (£) Source
GP in surgery 46 PSSRU41
GP at home 234 PSSRU41
Practice nurse in surgery 14 PSSRU41
Practice nurse at home 53 PSSRU41
GP telephone 28 PSSRU41
Practice nurse telephone 14 PSSRU41
Out-of-hours clinic 95 PSSRU41
Walk-in clinic 135 PSSRU41
Hospital day case 468 NHS Reference Costs 2013–201442
Outpatient 135 PSSRU41
A&E 135 PSSRU41
Intervention costs
Nurse support: face-to-face contact, weight related 7a PSSRU41
Nurse support: telephone, weight related 3.5b PSSRU41
Nurse support: e-mail, weight related 1.75c PSSRU41
Cost of provision of website per user 1.00 Trial estimate based on costs incurred
A&E, accident and emergency.
a Assumed half of the price of practice nurse in surgery.
b Assumed one-quarter of the price of practice nurse in surgery.
c Assumed half of the price of nurse support by telephone.
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The base case for the cost per weight lost analysis was that for the imputed case based on repeated
measures analyses, linked to the statistical analysis report in Chapter 3, chosen in view of the low
completion of the EQ-5D (< 50%). We also present the cost per QALY analysis based on imputed cases,
but given the extent of missing data caution should be used in interpreting such results.
Sensitivity analyses were conducted on complete cases, the cost per percentage achieving weight loss of
> 5% from baseline and without hospital admission costs.
Results
The pattern of use of the nurse support in the two intervention groups is shown in Table 25.
Approximately 70% of those in each intervention group had at least one contact [POWeR+F, 72%
(193/269); POWeR+R, 67% (181/270)]. Contacts could be face-to-face, e-mail or telephone contacts. As
expected, the mean face-to-face contacts were highest in the POWeR+F group at 1.50 per patient, but a
few also occurred in the POWeR+R group (mean 0.10). The mean total number of contacts was slightly
higher in the POWeR+F group, at 3.23, than in the POWeR+R group at 2.85.
Total costs
The total unadjusted cost by group (Table 26) put the cost per patient (including ‘nurse support’ in each
intervention arm) at £398 (95% CI £296 to £500) in the control group; this was slightly higher at £401
(95% CI £296 to £506) with POWeR+F but lower in the POWeR+R group at £349 (95% CI £266 to
£432). These cost differences were not statistically significant.
The pattern of service use by arm was fairly similar, as expected. The main costs in each group were those
of medications, at around one-quarter of the total. The mean frequency of GP consultations was similar, at
around 1.44 per person, and varied little between groups. Hospital admissions were rare (11, 7 and 6 in
the control, POWeR+F and POWeR+R groups, respectively), but, given their high unit cost, they accounted
for around one-quarter of the total mean cost in the control and POWeR+F groups and only 18% in the
POWeR+R group. Although the number of patient admissions was similar in both intervention groups, the
lower total cost in the POWeR+R group was mainly because participants in this group incurred less cost.
The mean cost per patient of nursing support in the POWeR+F group was £15.56, and in the POWeR+R
group was £7.99. Adding the estimated cost of the web raised these to £16.56 and £8.99, respectively.
The cost results estimated by bootstrapping using imputed cases (Table 27) remained largely unchanged,
as expected. The main total costs based on the bootstrapping method shows the same pattern as above,
with £424 (95% CI £338 to £515), £447 (95% CI £358 to £544) and £388 (95% CI £315 to £468) for
the control, POWeR+F and POWeR+R groups, respectively. Compared with the control group, POWeR+F
had slightly higher mean costs at £23 (95% CI –£105 to £152) and POWeR+R had lower costs at –£36
(95% CI –£154 to £81). None of these differences was statistically significant.
TABLE 25 Summary of the intervention-specific nurse support
Group Contacts Complete cases, mean (95% CI); n Intention to treat, mean (95% CI)
POWeR+F (n = 269) Face to face 2.33 (2.17 to 2.49); 173 1.50 (1.33 to 1.67)
E-mail 2.13 (1.91 to 2.35); 116 0.92 (0.76 to 1.08)
Telephone 1.82 (1.6 to 2.03); 120 0.81 (0.67 to 0.95)
Total 4.50 (4.25 to 4.74); 193 3.23 (2.93 to 3.53)
POWeR+R (n= 270) Face to face 1.56 (1.13 to 1.98); 18 0.10 (0.05 to 0.16)
E-mail 3.13 (2.94 to 3.32); 173 2.00 (1.79 to 2.22)
Telephone 1.62 (1.47 to 1.77); 124 0.74 (0.63 to 0.86)
Total 4.25 (4.05 to 4.46); 181 2.85 (2.58 to 3.13)
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TABLE 26 Mean NHS resource use in each group (2013/14 prices)
Cost use categories Mean (95% CI) for those using service; n Mean for all (95% CI)
Control group (n = 279)
Cost (£)
All costs 428 (320 to 537); 259 398 (296 to 500)
Medication 271 (191 to 350); 119 116 (78 to 153)
GP consultation 71.69 (60.22 to 83.16); 142 36.49 (29 to 44)
Outpatient attendance 548 (388 to 709); 49 96.29 (60 to 133)
Hospital admission 2569 (1158 to 39,805); 11 101 (26 to 177)
Number of cases
Medication usage 3.23 (2.84 to 3.62); 119 1.38 (1.13 to 1.63)
GP consultation 2.68 (2.33 to 3.03); 142 1.37 (1.13 to 1.60)
Outpatient attendance 4.06 (2.87 to 5.25); 49 0.71 (0.44 to 0.99)
Hospital admission 1 (1 to 1); 11 0.04 (0.02 to 0.06)
POWeR+F (n = 269)
Cost (£)
All costs 431 (319 to 543); 250 401 (296 to 506)
Medication 191 (150 to 232); 140 99.6 (75 to 124)
GP consultation 82.77 (67 to 97); 148 45.54 (36 to 55)
Outpatient attendance 534 (373 to 695); 47 93.35 (57 to 130)
Hospital admission 3986 (1840 to 6132); 7 104 (17 to 191)
Nurse support 21.68 (20.59 to 22.77); 193 15.56 (14 to 17)
Number of cases
Medication usage 2.84 (2.55 to 3.13); 140 1.48 (1.25 to 1.70)
GP consultation 2.74 (2.37 to 3.11); 149 1.52 (1.26 to 1.78)
Outpatient attendance 3.96 (2.76 to 5.15); 47 0.69 (0.42 to 0.96)
Hospital admission 1.43 (0.70 to 2.16); 7 0.04 (0.01 to 0.07)
Nurse support 4.5 (4.25 to 4.74); 193 3.23 (2.93 to 3.53)
POWeR+R (n = 270)
Cost (£)
All costs 386 (296 to 477); 244 349 (266 to 432)
Medication 215 (150 to 279); 122 96.99 (65 to 128)
GP consultation 62.97 (53 to 73); 126 29.39 (23 to 35)
Outpatient attendance 530 (375 to 684); 52 102 (64 to 140)
Hospital admission 2794 (997 to 4591); 6 62.09 (5 to 119)
Nurse support 11.92 (11.22 to 12.62); 181 7.99 (7.17 to 8.81)
Number of cases
Medication usage 3.17 (2.80 to 3.55); 122 1.43 (1.18 to 1.69)
GP consultation 2.55 (2.20 to 2.91); 127 1.20 (0.97 to 1.43)
Outpatient attendance 3.92 (2.78 to 5.07); 52 0.76 (0.47 to 1.04)
Hospital admission 1.33 (0.48 to 2.19); 6 0.03 (0.00 to 0.06)
Nurse support 4.25 (4.05 to 4.46); 181 2.85 (2.58 to 3.13)
Note
All costs constitute the total of all costs incurred. The main components of all costs were GP consultations, medications,
outpatient attendance, hospital admissions and nurse support contacts.
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EuroQol-5 Dimensions score and quality-adjusted life-years
EuroQol-5 Dimensions forms were completed by almost all at baseline, but completion fell to around
50% at 12 months, a figure that varied only slightly by arm (Table 28). Quality of life, as measured by the
EQ-5D, was similar in both intervention groups at baseline (POWeR+F, 0.824; POWeR+R, 0.816) and a
little higher than in the control arm (0.785). Both intervention groups showed a slight decline in quality of
life over time, whereas that of the control group improved.
Quality-adjusted life-years over 12 months, based on complete cases (< 50%), are reported in Table 29.
Compared with the control group (0.780), the crude QALY estimates for both POWeR+F and POWeR+R were
slightly higher (0.825 and 0.820, respectively). Bootstrapped estimates based on imputed data (Table 30)
indicated a similar pattern.
Incremental cost-effectiveness
The incremental cost per kilogram lost for POWeR+F versus the control group (Table 31) was £18 (95% CI
–£129 to £195), and for POWeR+R versus control it was –£25 (95% CI –£268 to £157). The point
estimate for the latter indicated that POWeR+R dominated the control group as it was more effective
and cost less, but the 95% CIs of this estimate range from negative to positive. Almost identical results,
in terms of both sign and magnitude, were obtained when the complete cases were used (Table 32).
The different ICERs in Tables 31 and 32 are a result of the effects of bootstrapping. The lack of difference
between these sets of results is attributable to the low level of missing data for this outcome.
The incremental cost per person achieving a ≥ 5% weight loss (Table 33) for POWeR+F versus the control
group was £312 (95% CI –£2481 to £3294) and for POWeR+R versus the control group was –£208
(95% CI –£2134 to £992). The point estimate of the latter was dominant but, again, with wide CIs
showing great uncertainty.
TABLE 27 Mean total costs per person based on bootstrapping methods
Group
Costs (£), mean (95% CI)
Total Incremental
Control 424 (338 to 515)
POWeR+F 447 (358 to 544) 23 (–105 to 152)
POWeR+R 388 (315 to 468) –36 (–154 to 81)
TABLE 28 Mean EQ-5D scores over 12 months in each group, based on complete data
Group Time point
Mean EQ-5D score for
complete cases (95% CI)
Number
completing % completion
Control (n= 279) Baseline 0.785 (0.757 to 0.812) 274 98
6 months 0.799 (0.764 to 0.835) 168 60
12 months 0.783 (0.742 to 0.824) 134 48
POWeR+F (n = 269) Baseline 0.824 (0.804 to 0.845) 267 99
6 months 0.823 (0.791 to 0.854) 169 63
12 months 0.820 (0.786 to 0.855) 139 52
POWeR+R (n= 270) Baseline 0.816 (0.790 to 0.842) 266 99
6 months 0.822 (0.787 to 0.857) 177 66
12 months 0.811 (0.770 to 0.851) 151 56
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TABLE 29 Mean QALYs over 12 months based on complete cases
Group Mean QALYs 95% CI
Control (n = 119) 0.78 0.74 to 0.82
POWeR+F (n= 122) 0.83 0.80 to 0.86
POWeR+R (n= 135) 0.82 0.78 to 0.86
TABLE 30 Bootstrapped estimates of mean QALYs over 12 months, based on imputed data
Group Mean QALYs 95% CI
Control (n = 279) 0.79 0.77 to 0.82
POWeR+F (n= 269) 0.82 0.80 to 0.84
POWeR+R (n= 270) 0.81 0.78 to 0.83
TABLE 31 Incremental overall NHS cost per kg of weight lost (ICER) compared with the control group, based on the
imputed data using repeated measurement
Group
Mean difference in
costs (£) (95% CI)
Mean weight lost
(kg) (95% CI)
Incremental cost (£) per
kilogram of weight lost
(95% CI)
POWeR+F vs. control 23 (–105 to 152) 1.49 (0.58 to 2.41) 18 (–129 to 195)
POWeR+R vs. control –36 (–153 to 81) 1.27 (0.34 to 2.19) –25 (–268 to 157)
TABLE 32 Incremental cost per weight lost (ICER) based on the complete data using repeated measurement
Group
Mean difference in
costs (£) (95% CI)
Mean weight lost
(kg) (95% CI)
Incremental cost (£) per
kilogram of weight lost
(95% CI)
POWeR+F vs. control 0.48 (–129 to 135) 1.56 (0.65 to 2.47) 0.31 (–198 to 207)
POWeR+R vs. control –43 (–161 to 74) 1.30 (0.39 to 2.21) –32.74 (–7 to 19,090)
TABLE 33 Costs, percentage maintaining 5% weight loss from baseline and incremental cost using bootstrapping
methods based on imputed weight data
Group
Costs (£), mean (95% CI) Percentage
maintaining
weight loss of
at least 5%
from baseline,
mean (95% CI)
Incremental
weight loss (%),
mean (95% CI)
ICER (weight loss %),
mean (95% CI)Total Incremental
Control 424 (338 to 515) 21 (17 to 26)
POWeR+F 447 (358 to 544) 23 (–105 to 152) 29 (24 to 34) 7.3 (0.9 to 13.7) 312 (–2481 to 3294)
POWeR+R 388 (315 to 468) –36 (–154 to 81) 32 (27 to 37) 10.3 (3.7 to 16.9) –208 (–2134 to 992)
Note
The means of incremental costs and incremental weight lost and ICERs between two groups are not directly derived from
the mean cost and mean outcomes in each group as a result of the use of the bootstrapping method.
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Incremental cost per quality-adjusted life-year gained
Table 34 provides a similar analysis to Table 31 but using QALYs based on imputed cases. After adjustment
for baseline EQ-5D scores, the difference in QALY increments for the POWeR+F group compared with the
control group was –0.007 (95% CI –0.030 to 0.014), and for the POWeR+R group was –0.012 (95% CI
–0.032 to 0.008). The ICERs, based on imputed data and adjusted for baseline (see Table 34), led to the
cost per incremental QALY for POWeR+F versus control of £1204 (95% CI –£35,636 to £38,404) and for
POWeR+R versus control of –£966 (95% CI –£26,621 to £27,765). Small differences in QALYs (close to
zero) resulted in wide CIs, which ranged in each instance from negative to positive.
Cost-effectiveness acceptability curves
The cost-effectiveness acceptability curves (Figures 2 and 3) for weight loss show the probability of each
intervention being cost-effective compared with the control group at various of levels of willingness to pay
per kilogram lost, including NICE’s suggested willingness-to-pay threshold of £100 per kilogram lost.
Compared with the control group, this puts the probability of being cost-effective at 88% and a 98% for
the POWeR+F and the POWeR+R groups, respectively.
The incremental cost per QALY analysis is complicated by the negative QALY increments for both
interventions versus control, which is unreliable as a result of missing data. For POWeR+F, the control
group was dominant, as it also cost less. For POWeR+R, which cost less than the control group, the ICER
was positive as a result of the division of two negative values. Given the uncertainty of these results, with
half of the EQ-5D values missing, cost-effectiveness acceptability curves are not reported.
Sensitivity analyses
Given the importance of the cost of each intervention, two issues were explored: one about differential
costing of the two interventions and the other about excluding hospital costs.
To recapitulate, the pattern of use of face-to-face, e-mail and telephone contacts by intervention arm
(see Table 25) put the total mean number of contacts at 4.50 for POWeR+F and at 4.25 for POWeR+R.
The mean nurse support cost per person was £21.68 and £11.92 in the POWeR+F and POWeR+R groups,
respectively. As noted in Methods, face-to-face contacts were costed at half the national average,
telephone calls at half and e-mails at one-quarter of that for face-to-face contacts. Therefore, how
sensitive are the intervention costs to changes in these assumptions?
TABLE 34 Costs, QALYs and incremental cost per QALY using bootstrapping methods based on imputed and
adjusted baseline EQ-5D scores
Group
Costs (£), mean (95% CI) QALYs
Total Incremental
Mean (95% CI)
(calculated
based on area
under the
curve)
Incremental,
adjusted
baseline EQ-5D
scores (95% CI)
ICER (£), mean
(95% CI)
Control 424 (338 to 515) 0.792
(0.769 to 0.815)
POWeR+F 447 (358 to 544) 23 (–105 to 152) 0.818
(0.798 to 0.840)
–0.007
(–0.030 to 0.014)
1203
(–35,636 to 38,403)
POWeR+R 388 (315 to 468) –36 (–154 to 81) 0.807
(0.783 to 0.831)
–0.012
(–0.032 to 0.008)
–966
(–26,621 to 27,765)
Note
The means of incremental costs and incremental QALYs and ICERs between two groups are not directly derived from the
mean cost and mean outcomes in each group as a result of the use of the bootstrapping method.
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Increasing the cost of face-to-face contacts in the POWeR+R group would make little difference, as the mean
number of such contacts was only 0.10 (see Table 25). Similarly, as the mean number of telephone calls was
almost the same in each group (mean of 0.81 and 0.74 in the POWeR+F and POWeR+R groups, respectively),
adjusting their unit cost would make little difference to the difference in cost between interventions.
The main difference between the two groups was the use of e-mails, with a mean number of 0.92 in the
POWeR+F and 2.0 in the POWeR+R groups (see Table 25). The mean cost in the POWeR+R group would
rise to that of the POWeR+F group only if e-mails cost the same as face-to-face contacts; this, however,
seems highly unlikely. The only indication we have of the relative costs of face-to-face and telephone
contacts is that in PSSRU, which is in turn based on the 2011 GP Worklife Survey.44 This did not include
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FIGURE 2 Cost-effectiveness acceptability curve of POWeR+F compared with control group based on average
weight loss (kg) from baseline during 12 months.
100
90
80
70
60
50
Pr
o
b
ab
ili
ty
 o
f 
co
st
-e
ff
ec
ti
ve
n
es
s 
(%
)
40
30
20
10
0
0 50 100 150
ICER ceiling threshold (£)
200 250 300
FIGURE 3 Cost-effectiveness acceptability curve of POWeR+R compared with control group based on average
weight loss (kg) from baseline during 12 months.
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e-mail contacts, which remain relatively uncommon between general practices and patients in the UK.
More work is required on costing such contacts. However, it seems inescapable that e-mail contacts cost
considerably less than face-to-face contacts, with the cost of telephone calls somewhere in between.
The key point, besides both interventions being of very low cost, is that the mean cost of POWeR+R was
less than the cost of POWeR+F.
Given that the inclusion of the costs of NHS services led to the POWeR+R group having the lowest
mean cost per patient, in turn caused mainly by very few hospital admissions, an exploration of
the cost-effectiveness based on exclusion of hospital costs was carried out.
When the cost of hospitalisations only was excluded, both interventions had a lower cost than the control
group, which, combined with the same weight reductions (see Table 31), resulted in dominance for both
over the control group.
Conclusions
Overall, both interventions were cost-effective in terms of weight loss, but less so in terms of incremental
cost per QALY. This was the case for our base-case analyses of cost per kilogram lost and per QALY, and
showed little variation in other analyses. The former result is more robust for several reasons, including the
relationship between QALYs and weight loss and the level of missing EQ-5D data. The cost per kilogram
lost is highly likely to be below NICE’s threshold of £100 per kilogram lost, but this conclusion is limited by
our lack of data on the maintenance of weight loss beyond 12 months.
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Chapter 5 Qualitative study with health
professionals
This study presents a qualitative process evaluation that explored health-care professionals’ (HCPs’)perceptions of delivering remote and face-to-face support to patients using POWeR+. Process
evaluations are recommended in national guidance,45 and can help to identify how health care is
implemented: the likely mechanisms through which an intervention produces an effect and important
factors within the health-care context that might influence the delivery and functioning of an intervention.
We were particularly interested in understanding what it was like for HCPs to provide support for patients
using POWeR+, as this could tell us more about whether or not the intervention might be feasible to
implement in primary care, and could highlight any modifications that would be important to ensure
its success.
Design
We used semistructured qualitative interviews to gain a rich, in-depth understanding of HCPs’ experiences
of supporting patients using POWeR+.
POWeR+
POWeR+ consists of two parts: one for patients and one for the HCPs who supported both intervention
groups. The development of the patient website is explained more fully elsewhere21,25,46 but, in brief, it
provided patients with a choice of two eating plans (low calorie or low carbohydrate) and two physical
activity plans (a walking plan, with free pedometer, or a plan for any other physical activity). POWeR+
aimed to help patients to develop self-regulation skills by promoting weekly weighing, weekly reviews of
eating and physical activity goals, as well as by providing cognitive–behavioural techniques in weekly
online sessions.
The HCP website provided brief information about POWeR+ and how to provide support to patients (this
information was also given on paper in HCP study files). The website also allowed HCPs to view patients’
recorded weekly weight and goals, and to send patients support e-mails.
In the first version of POWeR22 we gave HCPs access to detailed information about the patient website,
hoping that practitioners would therefore be able to give advice that was consistent with POWeR.
However, HCPs reported that they lacked the time to look at this information and usage analysis revealed
that very few had looked at these support pages. Taking a person-based approach,21 we redesigned the
HCP support for POWeR+ based on practitioners’ feedback. In POWeR+, practitioners were asked not to
give advice to patients; instead, all advice came from POWeR+ and the practitioners simply provided a
supportive relationship to promote adherence.
We developed the Congratulate, Ask, Remind (CARe) approach to facilitate a non-directive supportive
relationship, which would be easy to deliver and would fit with practitioners’ busy schedules. In addition to
being developed using a person-based approach, the CARe approach is also based on self-determination
theory.47 The CARe approach aims to provide an autonomy-supportive relationship, which can raise
patients’ autonomous motivation for behaviour change by promoting feelings of autonomy, competence
(feeling effective) and relatedness (understood and cared for by others).48 Autonomy-supportive
relationships with HCPs predict better weight-loss outcomes,45,48 as well as predicting outcomes in a range
of other health conditions.49 The theorised mechanisms of the CARe approach are explained in Table 35.
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Sampling and recruitment
The 54 HCPs who supported POWeR+ were nurses (n = 53) or health-care assistants (n = 1), and the
majority were female (n = 53). All HCPs were sent a study invitation letter, information sheet and consent
form. Nineteen female nurses expressed an interest in taking part and 13 were interviewed by telephone.
No significant new themes emerged with later interviews, implying that saturation had been achieved.53
Practitioners who chose not to participate noted that they did not have time.
Data collection
The telephone interviews were conducted between April and June 2014 by LP, a health psychology Master
of Science student who was given training in qualitative interviewing and analysis. LP had no prior
relationship with any of the HCPs interviewed. HCPs who agreed to participate posted a signed consent
form to the researcher prior to the interview.
Before each interview, LP explained that she was a postgraduate student, with no previous involvement in
the design or evaluation of POWeR+. The interviews explored HCPs’ experiences of providing support for
TABLE 35 The CARe approach: Congratulate, Ask, Remind
Guidance given to practitioners about CARe Theoretical basis
Congratulate the patient on any use of POWeR+
programme:
l You can congratulate them on any weight lost,
achieving goals, setting goals or just logging in!
l Even if they have not logged in or used POWeR+,
remember to be positive. They may have been ill or
on holiday
l If they have not used the programme yet, congratulate
them on consenting to take part in the study, which
shows they are interested in managing their weight –
just logging into the website is a step in the
right direction
Praise was focused on the process of behaviour change
(e.g. ‘great job on sticking to your goals’, or ’well done on
losing weight’) rather than focused on the person as a
whole (e.g. ‘you’re great at losing weight’). Process-focused
praise can enhance autonomous motivation,49,50 as well as
feelings of competence and relatedness.50 Praise was also
informational (‘That’s great that you have logged on and
had a look at POWeR+’) rather than controlling (‘Well done
you have logged on to POWeR+, as you should’), which also
supports autonomy.49,51 Participants who had not engaged
with behaviour change were not pressured, as minimising
pressure supports autonomy48
Ask the patient if they have any questions or concerns
about making lifestyle changes, and then:
l Ask the patient what solutions they would like to try –
remember, the aim of POWeR+ is to encourage people
to become their own health trainer, not to rely
on others
l Direct patients to their tools section (for further
information on a range of topics)
l If they have not lost weight, then ask if they have tried
using a food diary for a few days to work out what
foods or drinks to swap or cut down. You can show
them how to work this out using a calorie counter
(if they are on the low-calorie plan), if they need to
Asking about potential barriers and exploring possible
solutions with patients can build more autonomous
motivation.52 It could also help patients to feel understood
and cared for, and so enhance relatedness. In this case,
emphasis was put on discussing the patients’ (rather than
HCP’s) ideas of possible solutions to challenges, to help
build their feelings of competence and to help them to rely
on themselves, rather than the HCP, for solutions. If patients
were struggling to lose weight, then HCPs could suggest
that patients self-monitored their dietary intake more closely
for a short period of time to understand where they might
need to make changes, to help build feelings of competence
Remind the patient about future support from you:
l You can explain to patients that you will be following
their progress online, and that they can e-mail you for
advice about using POWeR+ if they want to
HCPs monitoring patients’ progress online could potentially
enhance external, rather than autonomous, motivation.
However, minimising pressure can help support,48 probably
negating some of this effect. This was achieved by
mentioning monitoring only in the context of telling patients
that they could access more support if they wanted to.
Providing choice (in this case about whether or when to
receive additional support) also helps to support autonomy.48
Offering the opportunity for additional support might also
enhance feelings of relatedness
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POWeR+ participants, their experiences of using the POWeR+ website and of the study procedures.
All interviews were audio-recorded and lasted between 23 and 46 minutes.
Analysis
All interviews were transcribed verbatim and imported into NVivo 10 (QSR International, Warrington, UK),
to allow systematic comparisons to be made across the data set. An inductive thematic analysis54 was
carried out, augmented with procedures from grounded theory.55 First, the researchers familiarised
themselves with the data. The interviews were then coded and a coding manual was created. This coding
manual was continually updated to reflect the ongoing analysis. Constant comparison was used to ensure
that codes were being used consistently and reflected the data.55 Codes that identified similar aspects of
the data were clustered together into themes. Inter-rater agreement on all the final codes and themes was
agreed with ES (a post-doctoral researcher), LY (a health psychologist) and LP. Deviant case analysis was
used to ensure that perspectives that diverged from dominant trends were not overlooked.
Results
Four themes were identified: HCPs’ perceptions and use of POWeR+, supporting patients in their use of
POWeR+, the impact of POWeR+ and comparisons to existing weight management services. These are
discussed in detail below.
Health-care professionals’ perceptions and use of POWeR+
Health-care professionals reported finding the POWeR website straightforward and easy to use:
It was, you know, easy to use. I didn’t have any problems using it.
HCP-13
I found it quite easy to sort of navigate around and you know, dip in and out of. Yeah, no I found it
quite, quite user friendly, certainly.
HCP-15
Practitioners’ views about the content of POWeR+ varied; some were very positive, describing the website
as ‘very good. It’s very comprehensive’ (HCP-09), whereas others felt that it was adequate: ‘basic I would
think, but quite satisfactory’ (HCP-12).
One feature of POWeR+ that HCPs found particularly valuable was the e-mail prompts, which reminded
HCPs of key actions that they needed to take, for example contacting patients for support appointments.
Practitioners viewed these as very helpful in their busy work environments:
It’s useful to have the e-mails just to flag up and I used to leave them in my inbox just as a reminder
until the patient you know had been dealt with.
HCP-15
A few practitioners voiced frustration that they could not see the information given to patients on the
POWeR+ website. They felt that seeing this information would have allowed them to understand more
fully what patients were referring to during consultations. However, some did acknowledge that their time
was very limited and, therefore, it might have been challenging to view this additional information:
I don’t know what they’re reading . . . they don’t understand that and I find that difficult. It would be
easier to talk to them about it if we knew what they were looking at.
HCP-08
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There is no time to sort of browse, so the things I’m saying to you that may well have been on there
and I didn’t actually get round to looking at them.
HCP-05
A few practitioners found it challenging to avoid giving patients specific advice, as they were used to
directing patients to what they thought was the best solution and worried that patients might expect this,
rather than the non-directive support used in the CARe approach:
Just to give general advice and nothing specific. So, that was hard, yeah, compared to my job where
you’re doing, yeah, the opposite all the time. So, that was a little bit difficult and I think perhaps a
little frustrating for some of the patients, that they didn’t get more out of me.
HCP-19
I’m not allowed to sort of, what’s the word, guide them too much am I, so, from that point of view so
all I can sort of do is point them in the direction of the website, you know, and it, sometimes you just
want to say something and you can’t, so I find that quite difficult.
HCP-07
Some HCPs suggested that it would have been good for the patients to have been able to leave comments
for the practitioner to see:
All I got to see was their goals and any weights they've logged in . . . if they’d made any comments
about how they’d had a particularly good week or bad week or anything like that, might’ve been
quite interesting, just to have sort of been able to see that as well.
HCP-18
Supporting patients in their use of POWeR+
Health-care professionals supported patients in both the face-to-face and remote support groups. HCPs
enjoyed providing face-to-face care, and some expressed a preference for this rather than providing
remote support:
Ideally I’d like everybody to be in a face-to-face group really. That was the most satisfying for us as
research nurses I think, because as we are practice nurses as well we work with people all the time
so we’re not so used to communicating online with people, and I feel you get far more out of a
conversation if you’re actually looking at someone.
HCP-05
Some HCPs felt they got the best response from participants in the face-to-face support group:
Those that were in the remote group I felt really had to have a lot more willpower just to keep
going really, and with faceless e-mails coming, but those that were in the face-to-face groups did
really well.
HCP-05
However, some practitioners did sometimes struggle to get patients to attend appointments.
Views about remote support were mixed: on the one hand some nurses found face-to-face support more
enjoyable, but on the other they understood that remote support might be more practical for some patients:
I suppose the face to face is nicer from the relationship you get with the patients, but on the other
hand the e-mail can be perfectly efficient and a lot of people lead very busy lives, they don’t want to
be coming in.
HCP-06
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It appeared that some HCPs did not view remote support as support at all; one nurse noted that patients
in the remote support group would ‘probably (be) disappointed that they didn’t get any support’ (HCP-12).
Some HCPs reported that remote support was difficult, as patients were not always available by telephone.
Equally, patients did not always reply to the supportive e-mails, meaning that nurses did not know
whether or not their support was helping:
I didn’t go about phoning because that was just too difficult ‘cause when you’re in the surgery they
might not be there . . . so it’s actually easier for people to e-mail them.
HCP-08
I wasn’t sure whether the person had got my e-mail maybe, or if there was no feedback, so if they
hadn’t logged on or something, then I had no means of knowing if they were interested any more.
HCP-13
The impact of POWeR+
Participating in the POWeR trial was reported to impact on practices in a variety of ways. A small
number of nurses reported that POWeR+ raised their awareness of the damaging impacts of obesity
on physical and mental health, as well as how much improvement weight loss could make to health
conditions:
We’ve had one lady who’s gone from being hypertensive on two therapies to now on no medication
at all . . . that was a huge sort of wake-up call to me actually how much difference you could make to
someone’s life.
HCP-09
The availability of POWeR+ was occasionally viewed as a useful opportunity to help other nurses and GPs
to broach the topic of being overweight with patients:
[Practice staff] were quite keen to put people my way and I think sort of GPs and nurses found it a
useful place to send people because weight loss is quite a difficult subject sometimes, it can be, um,
can be quite hard to either broach or work through so I think it was useful that they had something
that was on offer.
HCP-04
There were mixed views on the impact that providing support had on practitioners’ time. HCPs from
research-active or flexible working practices felt that supporting patients with POWeR+ had only a little
impact on practice time. For HCPs who did not have time allocated specifically to research, managing the
logistics of providing support for patients could be challenging. Booking time out of their diaries to provide
support for POWeR+ patients was reported as a good solution:
For the first few weeks I did feel I was possibly a little bit behind . . . Obviously, seeing the patients is
fine ‘cause they were booked into my clinic so I had that time, but it was the follow-up over phone
calls or e-mails. So once I realised that and I could book the time then I managed to sort of keep on
top of it much more.
HCP-18
Comparisons to existing weight management services
Health-care professionals drew comparisons between POWeR+ and what was available to patients through
their practice or externally in the form of slimming clubs and groups. Many practitioners discussed how
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their practice offered a fairly limited service for people who wanted to lose weight. POWeR+ was,
therefore, seen as a useful alternative:
We don’t do specific clinics. Some people just come in for, to be weighed. I don’t give them specific
advice really, it’s just to come in and get weighed and have a little chat.
HCP-12
We need a standard response, and I think having the POWeR tools means we’re all singing from the
same hymn sheet.
HCP-09
Some HCPs did report that they could refer patients to external weight management programmes.
Others reported that ordinarily they would allow patients to come into the practice to weigh themselves,
but that formal support was not available. One HCP mentioned that routine weighing had stopped for
cost reasons:
We did offer patients regular sort of weigh-ins so to speak. If they wanted to they could come back
every couple of weeks or a month but the practice has since then decided that we wouldn’t be
offering this service because it was, this will sound terrible, a waste of money.
HCP-05
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Chapter 6 Qualitative process interviews with
patients
Methods
Participants
Telephone interviews were conducted with 31 POWeR+ programme users between August 2013 and
June 2014. Purposive sampling was applied to ensure broadly similar representation of males and females
from both the remote and face-to-face support groups, as well as a mixture of high (at least four sessions
completed) and low (fewer than four sessions completed) intervention users. A total of 133 trial patients
were invited to take part in an interview, 111 of whom were randomly sampled; the remaining 22 were
purposively selected because of their ‘low user’ status. Each potential participant was sent an information
sheet, consent form and response sheet by post. Those who returned completed consent forms and
response sheets were contacted by a member of the study team to arrange an interview. Ethics approval
was granted within the main trial and all participants were made aware that participation was both
confidential and voluntary.
Procedure
Semistructured telephone interviews were conducted with 14 remote support and 17 face-to-face
support patients. Interviews explored patients’ expectations of POWeR+, experiences of the POWeR+
programme, experiences of using the POWeR+ website and experiences of nurse support. Interviews
were audio-recorded and lasted between 30 and 80 minutes. Thirty-one participants were felt to be
sufficient to capture a range of views from varied demographics, with no new themes emerging from
later interviews.
Data analysis
Interviews were transcribed verbatim and identifiable data were removed. Inductive thematic analysis of
each transcript was carried out,54,56 supported by the use of NVivo 10.0 software, and coded into emerging
categories or themes, which represented frequent patterns of meaning within the data set. Deviant case
analysis was used to ensure that perspectives that diverged from dominant trends were not overlooked.57
Analysis was iterative, with ES and RD independently reading and rereading each transcript. The initial
coding structure was revised to develop a coding manual based on consensus and inter-rater agreement
between three members of the research team, with an audit trail maintained throughout. The final
breakdown of coded themes can be found in Table 36.
Results
Fifteen (48%) women and 16 (52%) men aged between 45 and 88 years (mean 61 years) took part in
individual telephone interviews. Full demographic details are shown in Table 37.
Four themes were identified: reactions to the POWeR+ website content and function, changes to thinking
and lifestyle, motivators of and barriers to change, and using POWeR+ with and without support (see
Table 36).
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TABLE 36 Themes and subthemes
Subtheme Content
Theme 1: reactions to the POWeR+ website content and function
Website perceptions Participants’ views on overall appearance, design, layout and navigation
of the website
Participants’ views on acceptability of information contained within
the website
Participants’ views on interaction and engagement with the website
User views on the optional links for more information contained in
the website
Accountability Participants’ desires to be able to account for themselves
Non-judgemental Participants’ views on feeling ‘judged’
Computer confidence Participants’ views on their computer confidence
Views towards POWeR+ eating plan User acceptance of eating plan content and format
Views towards POWeR+ physical activity plans Users’ views of the POWeR+ physical activity advice
Views towards goal-setting Users’ views of POWeR+ goal-setting
General views towards goal-setting Users’ general perceptions of goal-setting
Theme 2: changes to thinking and lifestyle
Awareness raising Participants’ accounts of how POWeR+ raised their awareness of food
and physical activity requirements
Changed habits Participants’ descriptions of how they have changed eating and exercise
habits as a result of participating in POWeR+
Changes to eating Users’ accounts of changes made to their eating as a result of the
eating plan advice in POWeR+
Changes to physical activity Users’ accounts of changes made to their physical activity as a result of
the advice from POWeR+
Psychological outcomes Participants’ accounts of how POWeR+ made them feel better about
themselves
Focused thinking Participants’ accounts of how POWeR+ helped them to focus on their
weight change efforts
Theme 3: motivators of and barriers to change
Motivated to change Participants’ accounts of being motivated to change
Pedometers Positive and negative reflections of the POWeR+-issued pedometer
General barriers to change Participants’ accounts of life factors that acted as barriers to change
Barriers to adopting physical activity changes Participants’ accounts of health and injury issues that restricted physical
activity
Overcoming barriers Participants’ accounts of overcoming perceived barriers
Theme 4: using POWeR+ with and without support
Nurse support Users’ perceptions of level of support
Users’ perception of support provider
Outcome of nurse support
Difficulties accessing nurse for support
Need for human contact Users’ views on the need for support
Comparison of POWeR+ to slimming clubs Users’ comparisons of POWeR+ to slimming clubs
Usage patterns and reasons for usage Accounts of usage frequency and patterns
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Theme 1: reactions to POWeR+ website content and function
Website perceptions
The majority of participants reported positive perceptions towards the POWeR+ website, largely based on
ease of use and accessibility. They perceived the design and layout to be logical, yet also found the content
interesting and informative. Even participants who felt that their information technology skillset may be
lacking reported feeling positively about the website:
It’s quite easy to use and I’m not that computer savvy and I found it quite easy to get into the system
once I had sorted things out, so it was quite good.
Male, aged 60 years, face-to-face support, high user, 37A04
Other participants were more critical, reporting that they would prefer if the website allowed them to
account for any health conditions that had restricted them from doing what POWeR+ suggested, their
absence from the website as a result of holidays or illness, or their struggle to lose weight. For several
participants, importance was placed on being able to explain their behaviour:
Participant: There is nowhere you can say well I am sorry I am going to be putting on weight, I am
going on holiday, but I thought that might be useful if you could have something that you could
explain why things are going as they are going.
Researcher: And what would you like to be done with these comments?
Participant: It is just to let the person that is doing the survey like yourself, you can think well that
weight has gone up that week, and she hasn’t been on for 2 weeks and it would just be letting you
know why.
Female, aged 59 years, remote support, high user, 14A06
A small number of participants mentioned already being familiar with the information and discussed the
design and content of the website, perceiving it to be less engaging because of what they felt was a
somewhat condescending tone.
Views towards eating plans
Participants held contrasting views of the POWeR+ eating plan format. Those who viewed the plan more
positively reported finding the plan both helpful and straightforward, describing the flexibility and variety
of the format as beneficial:
What I like about it is it gives you a list of green and amber and red, so what you can eat on the
green list and what to avoid and so on, which I found quite good, I mean I have tried every diet you
can think of, and the problem is that eventually you put the weight back on, and I think this is a more
sensible way of doing it, because you can eat normally.
Female, aged 66 years, remote support, high user, 39A06
TABLE 37 Demographic characteristics of sample by support group (n= 31)
Characteristic
Group
POWeR+R (n) POWeR+F (n)
Gender (male/female) 5/9 11/6
Age (< 65 years/65+ years) 7/7 14/3
Usage (low/high) 3/11 2/15
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In contrast, a small number of participants suggested ways in which they felt that the plan could be
improved, for example by making it more prescriptive with specific menus to follow. However, there was
acknowledgement that prescribed meal plans may not be as beneficial in the long term:
I think it [having a set meal plan to follow] would have been to a certain extent easier at the
beginning, but I don’t think it would of actually adjusted my attitudes and thinking which it [POWeR+]
has done. So I think that is the bonus that the actual programme is designed to change your attitudes
to foods, your attitudes to eating.
Male, aged 64 years, face-to-face support, high user, 07A02
Views towards physical activity plans
About one-third of participants spoke positively about the physical activity plans, perceiving them to be
straightforward and clear. In particular, participants reported liking the way that targets were provided for
them to alter and work towards, and that the plans prompted them to reflect on personal physical activity
by providing ideas about how to increase activity levels.
Many participants were more critical of the plans, with most negative discussion centred on the way
POWeR+ was set up to record their daily and weekly exercise. Specific critiques included finding daily
exercise recording too time-consuming, feeling that age and physical activity abilities were not accounted
for, and not having the option to record activities that were not listed.
Goal-setting
Some participants spoke about goal-setting, reporting that setting regular goals and receiving the
feedback from the goal review process was beneficial as it provided encouragement to keep progressing:
It is always down to you, and doing POWeR+ has shown that to me, it’s down to you, and the
discipline of writing it down has been excellent, that works very well, writing a plan and knowing
what you are doing, it’s very good.
Female, aged 66 years, remote support, high user, 01A16
In contrast, others found the process to be repetitive and unnecessary, although only one participant
reported that the compulsory goal-setting would deter them from completing the session content:
You have got to write down what your goals this week but I’m not prepared to do that, you see, I
don’t want to do all that, so you can’t just skip that section, unless you fill that section in you can’t get
to the next section.
Male, aged 62 years, face-to-face support, high user, 05A01
Theme 2: changes to thinking and lifestyle
Some participants discussed the impact that POWeR+ eating plans had exerted on their awareness about
personal food choices.
They reported a greater awareness of calorie and carbohydrate content as well as portion size, and felt
more confident in their ability to continue implementing this knowledge beyond the trial:
I shall take it [the eating plan] with me because I shall know what I can and can’t eat because that will
be really embedded hopefully by then.
Male, aged 64 years, face-to-face support, high user, 07A02
Specific changes reported by participants included a change in eating habits, such as cutting out certain
foods, looking at the nutritional content of the food before buying it, eating less or adding breakfast into
their daily routine.
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Theme 3: motivators and barriers to change
A small number of participants reflected on their level of motivation before, during and as a result of
POWeR+. Several discussed their need to lose weight as a criterion for surgery and, thus, had long-term
motivation to reduce their weight. A few others spoke about being in the ‘right frame of mind’ when
introduced to POWeR+ or explained that they had already begun to make changes and had hoped that
POWeR+ would give them the motivation to continue.
A number of participants described how the use of a pedometer as part of the trial had motivated them
to alter physical activity habits by increasing exercise in order to meet specific goals. Participant accounts
included discussions of increasing how much walking they did on a day-to-day basis because they were
wearing and recording the data from the pedometer. In addition, several participants reported feeling
disappointed if they had not met their daily step target.
The most commonly discussed barrier to change was related to physical activity, with about half of
participants reporting a medical condition or physical problem/injury that restricted their engagement in
physical activities. Some participants felt unable to work around these perceived barriers, whereas others
reported having found alternative options to accommodate their reduced mobility:
I’ve had a knackered knee for many years, so I can’t necessarily go out and sprint down the road, so
what I’ve done is and what I know I can do and I enjoy doing is and it’s been effective is I will walk
and I tend to walk most evenings I had been walking most evenings.
Male, aged 60 years, face-to-face support, high user, 13A16
Theme 4: using POWeR+ with and without support
User perceptions of support
Participants, including those who felt that they had received minimal support, provided positive accounts
of their nurses, describing them as helpful and supportive:
She was great. I feel she’s probably someone I would like to have a cup of coffee with, you know.
She was very good and very encouraging.
Female, aged 64 years, face-to-face support, low user, 05A17
The nurse was very nice, very efficient, and very encouraging, when I said I have lost all this weight,
she was, ‘you should be pleased with yourself’, and very encouraging, it is nice to hear when you’ve
got someone on your side.
Male, aged 67 years, remote support, high user, 07A18
Face-to-face versus remote support
Some participants within each support group reported feeling positive about the type of support that they
had received. Many in the face-to-face group liked the encouragement that came from these meetings:
There was face-to-face [sic] meetings built into the programme, that was nice because it was someone
else who was there, who wasn’t if you like part of the family, or whatever, which was supportive
and encouraging.
Male, aged 64 years, face-to-face support, high user, 02A13
Similarly, there were those who were happy to have received remote support:
I was quite glad I got the remote one, because I don’t really want someone coming in and telling me
what to eat each week because I have done enough diets to know.
Female, aged 52 years, remote support, high user, 38A06
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For some remote users, knowing that the support was available if they wanted it appeared to be sufficient,
whereas others who wanted greater support felt that it would have helped to keep them motivated.
Conversely, other participants, regardless of allocated support group, reported feeling a lack of support
because of what they perceived to be infrequent nurse contact. For a small number, this was despite
making deliberate attempts to arrange support. It would appear, when comparing support records kept by
practice nurses with participant accounts, that the lack of support may be linked to participants’ differing
expectations and preferences about support levels.
Need for human contact
Related to perceived support, a proportion of participants discussed their need for greater personal
contact, with some suggesting that personal rather than remote contact would increase their motivation:
Everything that was on [the website] was positive, but I need more pushing in the right direction,
more support than what I did by just doing it on the computer.
Female, aged 48 years, face-to-face support, low user, 10A21
Again, these views were shared by participants in both support groups.
Comparison to slimming clubs
When discussing the support provided by POWeR+, many compared it with their experiences of slimming clubs.
For some, slimming clubs were seen as preferable because of greater perceived support and social interaction:
Whereas you’re in an environment with people that are there, like a slimming clubs, or other people
that’s encouraging you face to face, then it gives you more incentive than what it would personally for
myself on a computer.
Female, aged 48 years, face-to-face support, low user, 10A21
In contrast, others preferred POWeR+ because it was free to use and there was no guarantee that the
outcome of a slimming club would be any better:
I could have been paying, what, me [sic] fiver a week or whatever at the fat club and who’s to say the
results would have been any better?
Male, aged 65 years, remote support, low user, 28A12
For others it was a matter of convenience, as logging into POWeR+ was easier than attending slimming
club meetings. Finally, for two participants, the prospect of going and being weighed at a slimming club
was perceived as intrusive and embarrassing:
Being able to do it online and having the support, rather than having to leave your own home to get
weighed in front of other people . . .
Female, aged 49 years, face-to-face support, high user, 04A05
It’s not as intrusive as going to a class.
Female, aged 55 years, face-to-face support, high user, 06A14
POWeR+ usage
All participants provided accounts of how often, and under what circumstances, they used POWeR+.
Regular and occasional users alike described logging into POWeR+ to seek specific information to help
them with any issues that they were experiencing:
I went on every week to do my weigh in and then I would use it if and when I felt that I needed to
get some information that I wasn’t sure about.
Male, aged 49 years, remote support, low user, 04A05
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A number of reasons were given for decreased usage, with several participants explaining that they felt as
though they had got what they needed from the programme and had settled into a routine, perhaps only
logging in on occasion to remind themselves of specific information:
I think I’d gotten into a routine of losing roundabout a pound a week and was happy with doing that,
and so I thought I didn’t really think to use it a lot.
Female, aged 64 years, face-to-face support, low user, 05A17
You’ve got the weekly thing that you go on the e-mails and then, after a while, you get into a pattern
and you think, I don’t need this as much as I used to and I’m quite happy to carry on doing what I’m
doing and see where we go.
Male, aged 65 years, remote support group, low user, 28A12
Others reported not being in the right frame of mind to use the programme, being discouraged by the
perceived lack of nurse support or feeling that certain sections were no longer relevant based on little or
no changes to their goals:
There’s nothing more they can really add to me apart from do I want to stay on the same diet or do I
want to change it, do I want to change my goals? At the moment I’m happy with my goals, so hence
the reason I’m just keeping them, and I’m doing the same thing and I’m losing weight.
Male, aged 60 years, face-to-face support, high user, 13A16
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Chapter 7 Discussion
Summary of main findings
As far as we are aware, this is one of the few studies in primary care that has compared three feasible
briefer behavioural interventions using primary care staff for support to manage obesity. It demonstrates
that some participants managed in primary care can achieve clinically important weight loss over a
12-month period by combining simple written materials with occasional brief nurse follow-up, but that
significantly more will maintain clinically important weight reduction with the POWeR+ behavioural
internet programme and brief follow-up.
Strengths and limitations
The individuals who take part in trials are likely to be a relatively well-motivated group, but this is no
different from other trials in obese populations, and this is also the intended target group for which
intervention is most likely to be helpful. The study was large and pragmatic, mimicking the everyday
conditions in primary care settings, which had the disadvantage that the control group were not closely
controlled and so they undertook other activities to lose weight. This may have reduced the estimates of
benefit from the internet intervention, but this is also a strength as estimates are more realistic – this is
precisely what would happen in practice. The data also suggest that when controlling for such other
activities there was a modest change to the estimates.
Participants with obesity in primary care settings are notoriously difficult to follow up, and we were not
able to record weights in nearly 20% of individuals at 12 months. The estimates from the complete-case
analysis, and the analysis using recorded weights only, are therefore both likely to provide overestimates
of effectiveness; hence our primary analysis was the more conservative analysis using the imputed data.
However, in practice, multiple imputation modified the estimates only slightly, which suggests that
attrition bias was not a major issue. The qualitative study of health professionals used a rigorous
approach to thematic analysis, involving constant comparison, deviant case analysis and multiple analysts.
Another strength was that HCPs’ interview data could be triangulated with patient interviews, as well as
engagement and weight-loss outcomes from the POWeR+ trial, providing a fuller understanding of the
data. A weakness of this study was that only 19 practitioners volunteered to take part in this study, out of
the 54 who had taken part in the original trial; the views of those who took part may not be the same as
those who did not and could either over-represent or under-represent positive experiences of POWeR+.
The larger qualitative study of participants may also not have been representative of the whole cohort, but
in both qualitative studies there was a suitable range of participant characteristics and saturation of themes
was reached, so it seems unlikely that major issues were missed. A significant limitation is that, although
the intervention finished at 6 months and we were able to assess maintenance at 12 months, there was
no longer-term follow-up beyond 1 year. This is relevant not only for clinical effectiveness, but also
because the NICE modelling suggests that cost-effectiveness is sensitive to the duration of clinical
effectiveness. The major concentration on weight outcomes meant that there was much less good
coverage of the other outcomes (e.g. cholesterol, glucose, etc.).
A strength of the study was that Weight Concern was a partner in this project and chose to provide very
helpful panel-based input, particularly during the development of the intervention. Although this was well
justified, the project would have been strengthened by seeking additional patient and public involvement
engagement from other named individuals, perhaps sourced through additional channels.
DOI: 10.3310/hta21040 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 4
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Little et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
47
Effectiveness: main findings in the context of existing literature
We confirmed our previous findings12 that a brief intervention, using the novel approach of promoting
the use of healthy food-swap sheets and with brief follow-up for weighing, can be useful. In this study,
this strategy helped around 20% of participants to achieve a clinically important loss in weight. Many
patients in primary care do not get such simple, positive interventions, so we have probably underestimated
the effectiveness of POWeR+ in routine practice. As discussed above, the effectiveness in the control group
may also be, in part, due to motivated individuals who want to lose weight, and will do other activities to
help themselves (which about 50% did). In contrast, fewer individuals offered the POWeR+ intervention
undertook other activities.
The systematic reviews of interventions both in other settings and primary care suggest that both
intensive dietetic behavioural counselling and intensive follow-up are necessary to achieve effective weight
reduction.5,8,11 In contrast, we found that for a behavioural internet intervention, such as POWeR+, very
restricted face-to-face and remote follow-up is effective (median of four contacts, comprising 6-monthly
weighing, brief telephone calls and e-mails). The weight loss achieved with POWeR+ compares favourably
with other internet-based interventions, which on average10 (albeit with high heterogeneity) have led to
only short-term weight loss, of < 1 kg compared with no treatment controls or < 2 kg if combined with
face-to-face support (in a review based mainly on studies of motivated volunteer samples). Better weight
management results using an internet-based programme (around 5 kg) have been achieved only with
much more intensive human support (weekly 20-minute contact for 12 weeks, and then monthly up to
24-month follow-up). Encouragingly, the weight loss achieved by POWeR+ was comparable to the
best-performing interventions10 evaluated in a primary care setting, including that achieved by face-to-face
commercial programmes,30 but much less costly. The difference in mean weight loss of the intervention
groups when compared with the control group at the 12-month follow-up was smaller than the difference
compared with the control group at 6 months, so, although clinically important reductions in weight were
maintained from 6 to 12 months, particularly in the POWeR+R group, maintenance beyond 1 year
is unclear.
It is difficult to be sure that physical activity did not mediate intervention effectiveness because reported
leisure time physical activity is a relatively crude measure of physical activity. Nevertheless, the biases are
such that over-reporting of physical activity is more likely in the intervention groups, so it seems likely
that physical activity changed little. There was also little increase in the use of drugs, such as orlistat, for
managing weight. Thus, most of the effect of the intervention observed is probably a result of better
dietary management, which suggests that more effective engagement of participants for both physical
activity and appropriate drug treatment could result in significantly greater weight loss.
Health economic analyses
The total cost per kilogram for both interventions compared with control was low relative to NICE’s
suggested benchmark of £100. It was also well below the cost per kilogram loss in a recent systematic
review of commercial weight-loss programmes:53 among the five most effective interventions, average cost
per kilogram of weight lost ranged from US$155 (95% CI US$110 to US$218) for Weight Watchers®
(Weight Watchers International, Inc., New York, NY, USA) to US$546 (95% CI US$390 to US$736) for
orlistat. Economic analysis of the Counterweight Programme® (Counterweight Ltd; www.counterweight.
org/Programmes),58 in which the intervention cost £59 per patient and achieved 3 kg of weight loss, and
which modelled only impacts on diabetes mellitus, cardiovascular disease and colon cancer, demonstrated
that this level of weight reduction is likely to be very cost-effective, even allowing for weight gain following
the end of the programme. The likelihood of both POWeR+F and POWeR+R groups being cost-effective at
the NICE threshold was high, well over 80% (88% and 98%, respectively). A similar figure applied to the
probability of POWeR+R being cost-effective at this threshold relative to POWeR+F.
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This pattern of result is robust for several reasons: it held regardless of whether costing was restricted to
the intervention cost or extended to total cost, the results are based on data that are largely complete and
the directions of change were consistent at 6 and 12 months.
What is less expected was the finding that the POWeR+R group was more cost-effective than the POWeR+F
group. This was because it achieved similar changes in weight loss (depending on the measure), but at lower
cost. Its lower intervention cost was as expected, but the finding of a greater reduction in total cost was
not expected. The difference in total costs was not, however, statistically significant, but the cost of the
POWeR+R intervention was shown in sensitivity analysis to be highly likely to be less than that in POWeR+F.
The difference is mainly because of the lower cost of e-mails compared with face-to-face contacts.
The cost per QALY results are more difficult to interpret, mainly because both intervention groups recorded
small (not statistically significant) QALY losses relative to the control group. This is despite both losing more
weight than the control group. The QALY losses combined with inevitably higher intervention costs in both
intervention arms means that the control would dominate in an intervention cost analysis. When total
costs were used, one intervention cost more, and the other cost less than the intervention.
These incremental cost per QALY results are highly uncertain for several reasons: the decreases in QALYs
from baseline linked to greater weight loss may or may not be plausible; the high proportion of missing
data precluded more detailed exploration of the POWeR+ trial results; and the incremental cost per QALY
values were unstable, varying by type of analysis.
In summarising the economic data, both interventions deliver a low cost per kilogram lost, as judged by
NICE’s suggested threshold of £100 per kilogram lost. This is the case regardless of whether intervention
or total costs are used. The probability of each intervention being cost-effective compared with the control
was > 80%, with a similar figure applying to POWeR+R being more cost-effective than POWeR+F.
This result reflects the combination of statistically significant differences in weight loss but not in total
cost. Incremental cost per QALY results also indicated both interventions were cost-effective by NICE
standards, but the results were highly uncertain. Comparison of the two interventions generally showed
an advantage for the POWeR+R group as a result of its lower cost, however defined.
Even if weight loss had been identical in the POWeR+ remote group at all stages when compared with the
active control group, there was no evidence that health service costs increased. Furthermore, individuals
also apparently gained utility in feeling more enabled to manage their weight, and they undertook fewer
other weight-loss activities, suggesting that societal costs were probably lower in the POWeR+ remote
group.
Qualitative health-care professional study
Very few studies have previously looked at HCPs’ perceptions of providing support for online weight-loss
interventions. Two focus group studies have explored physicians’ perceptions of providing support for
patients using an online intervention.59,60 However, in both these studies the physicians provided infrequent
support to patients (every 3–6 months), whereas a coach provided patients with weekly intensive support.
Coaches were not interviewed in these studies, meaning that only the perceptions of physicians who
provided relatively sparse support were explored. Still, these studies usefully show that some physicians
perceive that they lack the skills to support patients losing weight59 and that others use dubious motivational
strategies, such as expressing frustration to patients who are not making progress.60 These findings suggest
that a more structured approach to providing support, such as the CARe approach, may be a useful tool for
practitioners wanting to support patients using online weight-loss interventions. The wider literature
examining HCPs’ experiences of providing support for an online intervention in chronic health conditions
tends to be of slightly lower quality, as a result of very small samples of practitioners (n = 4 or 5). This
literature suggests that HCPs see a lack of time as a key challenge to providing support,61,62 which is
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consistent with the findings of our study and represents a challenge to implementing digital interventions
into health-care settings.
Health-care professionals found it feasible and acceptable to support patients using POWeR+. As POWeR+
has been shown to be effective and can be provided at low cost, it may serve as a useful tool for the
treatment of obesity in primary care and public health. Digital interventions are rising in popularity and
additional human support is likely to maximise the effectiveness of these interventions. The CARe approach
shows promise as a model to guide human support for digital weight-loss interventions, and may be a
useful model to guide human support in digital interventions more broadly.
Qualitative study with patients
Overall, the POWeR+ website was viewed positively and as a trustworthy source of information relating
to weight loss, particularly when compared with other sources of information. Confidence in the accuracy
of the information was further enhanced by delivering the programme through participants’ usual GP
practices. Participants appreciated the flexibility offered by an online intervention and were complimentary
about the formatting and design of both the eating and exercise plans, although suggestions for
improvement included the provision of structured meal plans and example recipes. Participants provided
mixed views regarding the setting of short-term, realistic goals on a weekly basis, with some finding it
beneficial to make and review their goals regularly, but others perceiving this to be an unnecessary
inconvenience. Nurse support was also perceived positively by all participants, even those who reported
feeling that the level of support received was low. Nurse records kept during the trial show that
participants all received a regular amount of support in line with the trial guideline; however, there was an
indication that participants did not always perceive remote support, particularly by e-mail, as a form of
support. The findings suggest that participants would prefer support to include the chance to speak with a
nurse, or at the very least to know that someone was available for them to talk to as required.
Interpretation of results
Some participants in primary care maintain clinically important weight loss over a 12-month period by
promoting simple written materials without expert dietetic support, but significantly more will achieve
clinically important weight reduction with a behavioural internet programme and brief remote follow-up,
and resource use is not likely to increase. HCPs find POWeR+ both feasible and acceptable to use in
daily practice.
Implications for health care
Practices could feasibly consider implementing a weight management approach with internet-based
support for behaviour change (such as POWeR+R) among their obese patients, because it likely to be more
effective and more efficient than brief interventions using simple dietary advice.
Future research implications
1. Many individuals did not continue using the POWeR+ website and, given the evidence that those who
did lost rather more weight, a research priority is to identify clinically effective and cost-effective ways of
continuing to engage individuals.
2. Given the utility of POWeR+ with brief support in primary care, the question then arises of what public
health benefit might accrue from using POWeR+ in community settings and what magnitude and
nature of support is necessary, such as a central facilitator or pharmacy support, in order to achieve
effective weight control.
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3. Very few participants were engaged in using drug management of their weight problems despite this
being intended as part of the package, and few individuals increased physical activity; an implementation
study to develop and trial a complex intervention to address both these issues is warranted.
4. Future research to test the effectiveness, acceptability and feasibility of the CARe approach as a method
for providing human support for digital interventions in a range of health conditions is warranted.
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Appendix 1 Intervention description: POWeR+
The text in this appendix has been reproduced from Little et al.26 under the terms of the CC BY 4.0licence (https://creativecommons.org/licenses/by/4.0/).
POWeR+ is an automated online intervention to support weight management over 1 year. It was adapted
from an earlier version (POWeR), which was extensively trialled and shown to improve weight loss.
Development was informed by the person-based approach, which employs an iterative process of in-depth
qualitative user testing and a theoretical basis involving the principles of self-determination theory and
techniques from cognitive–behavioural theory.
POWeR+ was designed to provide support for sustainable long-term self-management of weight. Based on
our early piloting it was clear that patients wanted choice and that this would increase engagement;
patients therefore choose either a low-calorie eating plan (a reduction of around 600 calories a day) or a
low-carbohydrate eating plan (a carbohydrate limit of 50 g a day). Users can base their eating plan on a
traffic light system that categorises foods into those that could be eaten freely (‘green’), in moderation
(‘orange’) or very sparingly (‘red’). The low-carbohydrate eating plan categorises most vegetables and
some fruits as ‘green’ and categorises only very high-sugar and starchy foods as ‘red’, and is therefore
compatible with a sustainable healthy diet. Patients are also encouraged to increase their physical activity
levels by choosing either a walking plan (in which case they can request a pedometer) or a self-selected
mixture of other physical activities.
POWeR+ focuses principally on fostering users’ self-regulation skills for autonomously self-managing their
weight rather than providing detailed dietetic advice. Throughout POWeR+, users are taught active
cognitive and behavioural self-regulation techniques (‘POWeR tools’) to overcome problems such as low
motivation, confidence or relapse. Evidence is provided for the effectiveness of these techniques and
examples given of how others have successfully used them (‘POWeR stories’). POWeR+ emphasises
forming healthy eating and physical activity habits that should become non-intrusive and require little
effort to sustain. POWeR+ is tailored by gender, using language and ‘POWeR stories’ designed to appeal
to both men and women.
The intervention was developed based on behavioural theory and evidence from existing successful
interventions, with very extensive iterative qualitative piloting with a wide range of users from the target
population to check usability, accessibility and acceptability, and to elicit and respond to user views.
Aspects of POWeR+ that were modified from the original prototype POWeR intervention included use of
game-based techniques (i.e. sessions grouped into stages through which the user advances), addition
of extensive novel content (extra sessions to maintain interest for a longer period), shorter sessions
(to enhance engagement), and improvements to usability and navigation.
Overview of the four stages of POWeR+
Stage 1: users are tunnelled (i.e. they cannot proceed to a session until they have completed the previous
session) through three core sessions introducing them to POWeR+ and guiding them through the process
of setting and reviewing weekly goals (Figure 4). There are three components to the goal review:
1. recording weight
2. choosing an eating plan from:
¢ a low-calorie diet
¢ a low-carbohydrate diet
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3. choosing a physical activity plan:
¢ increasing walking using a provided pedometer and recording the weekly step count
¢ choosing any other physical activity and setting weekly goals.
Participants may opt to change their plans after their weekly goal review at any point during
the intervention.
Stage 2: users have free-choice access (i.e. they can access the sessions in any order) of sessions 4–10.
Goals can now be reviewed weekly and users can view their progress on a graph. If a user misses 1 week
of goal review, they may still review their goals the following week. After all sessions are completed or a
period of 7 weeks has passed since the stage was started, stage 3 sessions become available.
User enters weight
Option to keep or change current goal
Option to keep or change current goal
Personalised feedback given based on whether
• user has gained weight
• user has lost weight
• user’s weight has stayed the same
• user’s weight has dropped into a lower BMI category
User enters how many of their 
eating goals they have met
If user is on either eating plan
Personalised feedback given based on whether
• user has met all of their goals
• user has partly met their goals
• user has not met any goals
User enters how many of their
goals they have met
If user is on ‘mix of physical activity’ plan
Personalised feedback given based on whether
• user has equalled or exceeded their step goal
• user has not met their step goal
User enters number of 
steps taken
If user is on ‘walking’ plan
Personalised feedback given based on whether
• user has met all of their goals
• user has partly met their goals
• user has not met any goals
1 week
FIGURE 4 Overview of weekly goal review. This figure has been reproduced from Little et al.26 under the terms of
the CC BY 4.0 licence (https://creativecommons.org/licenses/by/4.0/).
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
60
Stage 3: users have free-choice access to sessions 11–17 and continue to complete weekly goal reviews.
After all sessions are completed or a period of 7 weeks has passed since the stage was started, stage 4
sessions become available.
Stage 4: users have free-choice access to sessions 18–25 and continue to complete weekly goal reviews.
Throughout the intervention, weekly e-mails are sent to remind users to complete their goal review.
Set periods of inactivity at various points during the intervention also trigger e-mails prompting users to
return to either complete sessions or complete their goal review.
TABLE 38 Overview of POWeR+ stages and session titles
Session number Description
Stage 1 (user is tunnelled through these sessions)
1 part 1 Introduction to POWeR+
1 part 2 Introduction to goal-setting and weekly weighing
2 Getting support from other people
3 Physical activity
Stage 2 (free-choice sessions, these are unlocked once user completes session 3)
4 Setting the strongest plans: mini session
5 Controlling your cravings
6 Stretching your physical activity
7 Setting up your environment to help you lose weight
8 Dealing with slip-ups
9 How to break bad habits: mini session
10 How to develop your new healthy identity: mini session
Stage 3 (free-choice sessions unlocked once user completes stage 2 or after 7 weeks)
11 Eating when times are tough
12 Eating out
13 Being drink aware
14 Take on a physical activity challenge: mini session
15 A quiz to show you which tricky situations you are best at dealing with and which you still need
to work on: mini session
16 Winning against temptations: mini session
17 When losing weight gets hard: mini session
Stage 4 (free-choice sessions unlocked once user completes stage 3 or after 7 weeks)
18 Using mindfulness to help you lose weight
19 Getting support from your family: mini session
20 Have you made your changes into habits? Take this quiz to find out: mini session
21 Make new habits easier by linking them to things you already do: mini session
22 A quick, easy tool to stop stress spoiling your weight loss: mini session
23 Busy lives
24 Maintaining your weight loss (we recommend that you complete this session last)
25 Successful celebrations (available only from the ‘tools’ page)
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